Skip to main content
Psychopharmacology Bulletin logoLink to Psychopharmacology Bulletin
. 2022 May 31;52(2):73–116.

The Prescriber’s Guide to the MAOI Diet—Thinking Through Tyramine Troubles

Vincent Van den Eynde 1, Peter Kenneth Gillman 1, Barry B Blackwell 1
PMCID: PMC9172554  PMID: 35721816

Abstract

This review article features comprehensive discussions on the dietary restrictions issued to patients taking a classic monoamine oxidase inhibitor (phenelzine, tranylcypromine, isocarboxazid), or high-dose (oral or transdermal) selegiline. It equips doctors with the knowledge to explain to their patients which dietary precautions are necessary, and why that is so: MAOIs alter the capacity to metabolize certain monoamines, like tyramine, which causes dose-related blood pressure elevations. Modern food production and hygiene standards have resulted in large reductions of tyramine concentrations in most foodstuffs and beverages, including many cheeses. Thus, the risk of consequential blood pressure increases is considerably reduced—but some caution remains warranted. The effects of other relevant biogenic amines (histamine, dopamine), and of the amino acids L-dopa and L-tryptophan are also discussed. The tables of tyramine data usually presented in MAOI diet guides are by nature unhelpful and imprecise, because tyramine levels vary widely within foods of the same category. For this reason, it is vital that doctors understand the general principles outlined in this guide; that way, they can tailor their instructions and advice to the individual, to his/her lifestyle and situation. This is important because the pressor response is characterized by significant interpatient variability. When all factors are weighed and balanced, the conclusion is that the MAOI diet is not all that difficult. Minimizing the intake of the small number of risky foods is all that is required. Many patients may hardly need to change their diet at all.

Keywords: MAOI, monoamine, oxidase, inhibitor, phenelzine, tranylcypromine, diet, tyramine, blood, pressure

The MAOI Diet—Partim Generalis

Introduction

Patients who are taking either a classic monoamine oxidase inhibitor (MAOI) antidepressant (phenelzine, tranylcypromine, isocarboxazid), or high-dose (oral or transdermal) selegiline, must be instructed to follow a tyramine-restricted diet; this is necessary because such (often highly effective) treatments cause considerable reductions in the body’s capacity to metabolize various monoamines, such as tyramine—which may be present, in varying concentrations, in both foodstuffs and beverages.

This review article offers a comprehensive overview of recent food science research on dietary tyramine, and on other biogenic amines (BAs) and amino acids (AAs) that may interact significantly with MAOIs (BAs: histamine, and dopamine; AAs: levodopa and L-tryptophan). Much of the focus is on tyramine, the main vasoactive amine implicated in blood pressure disturbances in MAOI patients.

It is important that recent food science data are consulted, because modern-day hygiene and production standards have resulted in significantly lower tyramine levels in most (but not all) foodstuffs.1 These findings have yet to filter fully through to medical publications. This review article is aimed at resolving the translational knowledge gap.

For many MAOI patients who already follow healthy eating patterns (e.g., no excessive amounts or aberrant combinations), the low-tyramine diet may involve few (if any) changes. The patient must follow the diet when MAOI treatment is initiated; the diet must be maintained for 2 weeks after MAOI cessation.

Monoamine Oxidase Inhibitors (MAOIs)

Monoamine oxidases (MAO) exist in two isoforms (MAO-A and MAO-B), and play a role in deaminating various (endogenous and exogenous) BAs;2 those of particular dietary relevance for the purposes of this Prescriber’s guide are tyramine (TYR), histamine (HA), and dopamine (DA). The effects on the metabolism of the AAs levodopa (L-dopa) and L-tryptophan (TRP) are also discussed.

MAOIs inhibit the breakdown of various (mono)amines—the extent to which this may occur depends on the specific properties of the MAOI used.

The ‘classic’ (irreversible and non-selective) MAOIs currently on the market are phenelzine (PLZ), tranylcypromine (TCP), and isocarboxazid (ISO); as they inhibit both MAO-isoforms, some dietary precautions are required. The details are discussed in the subsequent sections of this article.

Other, ‘non-classic’ MAOIs include selegiline (in essence an irreversible, selective inhibitor of MAO-B), and moclobemide (a reversible, selective inhibitor of MAO-A).

Selegiline is typically used in the treatment of Parkinson’s disease; it is selective for MAO-B at conventional doses of ≤10 mg/day, and does not require dietary modifications.3 At higher doses (typically 30–60 mg/day), selegiline also inhibits MAO-A, and becomes an effective (non-selective MAOI) antidepressant; restrictions in the intake of dietary TYR are required at such doses.4 A transdermal method of delivery was then devised so as to bypass hepatic metabolism1 (supplied as skin patches that deliver 6–12 mg/24 h); as a result, the lowest dose (6 mg/24 h) comes without dietary requirements5,6—but at higher doses, TYR restrictions do become necessary.7

Moclobemide, a selective MAO-A inhibitor, has not shown sufficiently effective in treating severe, ‘treatment-resistant’ depression—certainly when compared to the classic MAOIs (or to high-dose selegiline).8 Specific dietary precautions are not required with moclobemide,9 even at high doses of 600 mg/day.10

Collectively, the dietary recommendations in this Prescriber’s guide are intended, primarily, as a reference guide for physicians—it is important that they understand the principles of the MAOI diet, and can pass this (practical) knowledge on to their patients.

Biogenic Amines (BAs)

Biogenic amines (BAs) can be either endogenous to the human body, or can be absorbed from exogenous (food) sources. This guide is aimed, exclusively, at discussing the latter variety.

BAs can be present in various concentrations in both foodstuffs (raw or processed) and beverages; they are considered anti-nutritional factors:11 high BA levels are taken to be indicative of fermentation and/or of spoilage12—the latter process may be influenced by poor hygiene standards during manufacturing or storage (e.g., inadequate temperature control) of food products.13,14

Some BAs (such as TYR, HA, and tryptamine)15 are produced from the enzymatic decarboxylation of AAs;16 they are heat stable (i.e., they are not inactivated by cooking).17 The decarboxylating enzymes are also heat-tolerant, but comparatively less so; their action on AAs may be inhibited either by freezing (storage),13 or by the use of high-temperature preservation methods (e.g., pasteurization)18—but these enzymes may survive cooking19 (e.g., in some meats, boiling decreased HA levels, while grilling actually increased them).20 Other BAs (such as DA, spermine, and spermidine) are produced by hydroxylation- and/or condensation-reactions.15

While there are a variety of food-borne BAs,2126 this guide will limit its discussion to those that may be of particular relevance to MAOI patients: these are TYR (first and foremost), but also HA, and DA.

BAs: Aspects of Detection, Control, and Toxicity

There has been much progress in (and refinement of) measurement techniques of BAs in food27,28—that is (part of) why estimates of BA levels from older research studies are likely less accurate than those stemming from modern-day research samples. Such research is often expensive—but the various measurement methods employed (e.g., liquid or gas chromatography) are continuously finetuned,29 and data are rapidly and reliably accumulating; that is why recent reviews of BA toxicity are so important (and may indeed supersede some older data).21,22,3036

Aside from improved detection methods, considerable advances in food safety research have resulted in the use of various prevention and/or containment practices to reduce BA levels in foods;3739 these may be aimed either/both at limiting BA formation (by limiting the growth and/or decarboxylating activity of microbes), or at increasing the decay rate of already formed BAs.13,40

Naila et al. provide an overview of such existing and emerging methods; they include temperature control (e.g., proper refrigeration at <5°C), irradiation, addition of preservatives, modified atmosphere packaging, high hydrostatic pressure, using standardized starter-cultures (which have either non-amine forming, or amine-oxidizing properties), the use of high-quality base products, etc.13

TYR (vasoactive effects) and HA (scombroid poisoning) are the two BAs most commonly implicated in toxicity reactions in humans.4143 There are significant interindividual differences in bodily detoxification mechanisms (e.g., metabolization capacity of the various BAs), so that precise toxicity thresholds cannot be provided.44

Tyramine (TYR)

TYR is formed from the enzymatic decarboxylation of tyrosine (its AA precursor), and may gradually accumulate in a variety of foodstuffs, certainly when hygiene and/or production standards are not up to par. This process may then be further ‘aided’ by improper storage. That is why proper refrigeration of foods (at ≤4°C),45 verified by the use of an accurate fridge thermometer, is so essential (as some domestic refrigerators fail to maintain such temperatures).46

TYR Pressor Response

Following ingestion, dietary TYR is extensively metabolized by MAO in the intestinal lumen and in the liver (high first-pass clearance);4648 the remaining TYR then enters systemic circulation, where it may be taken up by sympathetic neurons, and is subjected to further deamination by intraneuronal MAO-A.49 It is clear that states of MAO inhibition drastically affect the amount of TYR that survives this process, whereafter it can induce the displacement of norepinephrine (and in some rare cases DA) from storage vesicles.50 This results in BP increases, with a typical duration of 1–3 h.51

Symptoms

A forceful, thumping heartbeat may be a first, tell-tale symptom of the TYR pressor response. It is accompanied by progressive BP increases (rapid onset: 30–60 min after ingestion; faster for liquids taken on an empty stomach); typically, the heart rate then slows down in response.5255 If systolic BP exceeds 180 mmHg, the rapid onset of a severe headache may be observed. Other symptoms include tightness in the chest, sweating, and pallor.

Treatment

Typically, ‘treatment’ for cases of excessive TYR ingestion is comprised of little more than monitoring BP (for 1–4 h), as hasty and alarmist treatment of elevated BP may produce more harm than good. Conservative treatment is strongly advised;46 e.g., sublingual nifedipine is contraindicated: there is a real risk of potentially severe hypotensive overshoots, possibly leading to cerebral hypoperfusion (which may result in permanent cortical blindness).56

Administering a benzodiazepine has a sedative, BP-lowering effect, and is therefore recommended as a first (and typically final) intervention step.46

In rare cases, when greatly excessive TYR has been ingested, the hypertensive episode may warrant additional care; it is the emergency physician who steps in, and treats these cases (hypertensive urgency or emergency)46,57 with best clinical judgment, taking into consideration the limited duration of the TYR-reaction (e.g., considers infusing phentolamine, which has an elimination half-life of only 19 minutes).58

TYR Dose and BP

There is significant interpatient variance in TYR pressor sensitivity (unmedicated or with MAOI)59—that is why empirical research-based individualization of dietary guidelines is so important. Gillman (2018)46 summarized the relevant research,6062 and extrapolated therefrom the following: TYR-sensitive MAOI patients may experience a (notable but not problematic) 30 mmHg increase in systolic BP following the ingestion of 20–30 mg TYR in a meal (or of only 10 mg TYR on an empty stomach; this is an aspect of intrapatient variability). For many MAOI patients, reaching a systolic BP of ≥180 mmHg would require the ingestion of >40 mg TYR in a meal.

The effect of TYR on systolic BP is dose-related, but the relationship is ‘non-linear’: small doses of TYR in a meal will cause (virtually) no BP increase; if the TYR dose is then increased in small and equal increments, there will come a dose point—‘when the amount of absorbed TYR exceeds the metabolising capacity of the MAO’63—which results, seemingly suddenly, in larger than (linearly) expected BP increases.64

There is some indication in early research by Blackwell et al.65 that the timings of TYR ingestion and MAOI ingestion may influence the magnitude and duration of subsequent BP increases (i.e., temporal proximity of TYR and MAOI ingestion seemed to result in greater BP effects)—but confirmatory research is required.

Those Who Test, Know Best

Treatment adherence is key;66,67 it improves treatment outcomes, and helps to limit both the occurrence and severity of adverse events—that is why patient compliance, or precisely the lack thereof, is a source of concern for physicians. That is also why, in the context of MAOI treatment, overly restrictive diet guidelines (or rules, even) do not work. Most publications (peer-reviewed or vulgarising) get this wrong; it appears simple and straightforward (and well-intentioned) to restrict, for reasons of safety (be they flawed or factual), the various foodstuffs and beverages that have been deemed impermissible throughout the decades of MAOI use—but this is a self-defeating strategy. Patients will learn, sooner or later, that some dietary restrictions ‘are more equal than others’, and that the BP effects from eating a slice of cheese may not always be as drastic as promulgated in much of the previous literature. Such an experience might lead to incorrect extrapolations, and to further dietary indiscretions—some of which may well be injurious.

It is therefore best that proper, science-based dietary guidelines are provided, and that matters of ‘diet adherence’ are discussed plainly and honestly; this may greatly improve patient-physician rapport, which is an important part of successful long-term MAOI treatment.

For these reasons, cautious and mindful ‘testing’ is allowed; this means consumption of low amounts of foodstuffs, that thus contain non-injurious TYR levels (see infra, ‘Partim Specialis’; some foods are still contraindicated), while carefully monitoring the BP response. Safety comes first when it comes to practical application—this Prescriber’s guide prefers, therefore, to err on the side of (excessive) caution, by suggesting that any such ‘testing’ ought to be firmly and openly discussed between the patient and the physician. The physician can, by utilizing the precepts outlined in this guide, help to educate the patient, thereby guiding him/her along a path of safely ‘testing’ TYR sensitivity. It is difficult to with great certainty approximate TYR levels in a particular food; that is why portion control and BP measuring are such helpful aids for the practical parts (e.g., the ‘testing’) of this guide.

In closing, any testing is to be undertaken in a careful and methodical manner, with the principles provided in this guide firmly in mind.

Histamine (HA)

Histamine (HA) is formed from the enzymatic decarboxylation of L-histidine, and may be present in high concentrations in protein-rich foods (e.g., meat, fish, blue or Swiss cheese)68 that are improperly stored.69 The consumption of HA-contaminated food may lead to one developing scombroidosis (spoiled fish of the Scombridae family are the prime culprits, hence the name).70

The symptoms of HA poisoning relate especially to effects on blood vessels, cell permeability and smooth muscles; they include headache, nasal secretion, bronchospasm, tachycardia, extra-systoles, hypotension (vasodilatory effect),44 edema (eyelids), urticaria, pruritus, skin flushing, and asthma.71,72 Clinical presentations may closely resemble IgE-mediated food allergies;73 measuring serum tryptase concentrations may help with differential diagnosis.74

MAOIs and HA

MAO is involved in the degradation of HA (a monoamine)75 via enzymatic methylation (histamine-N-methyltransferase),76 and so its metabolism in MAOI patients is altered, albeit to varying extents (based on the specific structural and pharmacological properties of the MAOI).77

The hydrazine-derivative MAOIs78 (PLZ, ISO) also inhibit diamine oxidase (DAO), and semicarbazide-sensitive amine oxidase (SSAO); both are enzymes that play a role in the degradation of HA.79 The increased sensitivity to dietary HA in patients taking isoniazid, an old antitubercular drug that is also a hydrazine-derivative (with modest MAOI potency) is well established;80 many such reactions have been described.8188

TCP is a propylamine89 (i.e., not a hydrazine-derivative); its DAO- and SSAO-inhibiting properties are comparatively weak.77,90,91

The conclusion is that, while TCP may reduce the metabolising capacity (i.e., breakdown) of dietary HA,77,92 the hydrazine-derivative MAOIs (PLZ, ISO) have considerably greater such effects.93 Patients who take PLZ or ISO are thus at greater risk for developing symptoms from excessive HA ingestion.94 An additional note of caution is therefore warranted for said patients: foods that may accumulate TYR (e.g., cheeses, meat, fish), may also have elevated HA levels.

Dopamine (DA)

Dopamine (DA) in the brain is an important catecholamine neuromodulator95—however, for the present discussion, it is important to distinguish between its central96 and peripheral97 effects, as DA does not cross the blood brain barrier in vivo (barring some limited delivery by intricate, scientifically novel means of administration).98100 Consuming DA-rich foods (e.g., large quantities of bananas)101 may cause elevations in plasma DA concentrations (via the release of endogenous DA, and/or via increases in L-dopa and/or other DA-precursors or -releasers);102 raised peripheral DA may in turn cause vasoconstriction, resulting in BP increases.103 The extent to which this may be relevant for MAOI patients is unclear due to a paucity of research data. Some portion control of DA-rich foods is thus advised.

Amino Acids

Substantial intakes of various dietary amino acids (AAs) may affect BP (long-term or immediate effects): methionine (increases homocysteine levels),104 and alanine may result in BP increases; whereas cysteine,105 arginine,106 histidine, and threonine may lower BP107—but there is a relative paucity of reliable (and independently verified) research data, so that definitive statements on the effects of AAs on BP are premature.

Interactions between dietary AAs and certain medications are complex, and may be bidirectional: absorption of AAs may be reduced by certain medications,108,109 and absorption of certain medications may be reduced by the simultaneous intake of dietary AAs.110

Any evidence indicating major implications for the MAOI diet is absent in the literature; it is likely that this may be taken to constitute evidence of absence of any serious interactions, given moderate consumption patterns.

Two AAs that are at times weaved into MAOI-related discussions (albeit not typically out of dietary concerns) are L-dopa, and TRP; they are summarily reviewed hereunder, if only to clear up potential misconceptions.

Levodopa (L-dopa)

Levodopa (L-dopa) is a precursor (but not a releaser) of DA111 (i.e., not an indirectly acting sympathomimetic like amphetamine),112 meaning the BP effects in MAOI patients are likely only (moderately) potentiated; see supra, ‘Dopamine (DA)’, for the presumable mechanistic explanation.

There is an analogy here between dietary L-dopa and TRP (see infra); it goes as follows: normal intakes of dietary TRP have not been reported to cause serious serotonin-mediated effects—and so one would expect, similarly, to find correspondingly limited effects of dietary L-dopa on BP.

L-tryptophan (TRP)

L-tryptophan (TRP) is an essential AA; it is a precursor of serotonin, and plays an important role in a great number of metabolic processes.113 There is a distinction to be made between (normal) dietary and (deliberately) supplemental quantities of TRP: experienced practitioners have been known to use TRP tablets/capsules as an augmenting agent with MAOIs;114 this is an advanced treatment strategy that may result in (typically mild to modest) serotonin-mediated side-effects when comparatively high doses of TRP (≥2 g) are used (or if the starting dose/increase rate is too high).58 By contrast, dietary TRP is not normally ingested in such high amounts, even in a TRP-rich meal (e.g., ∼400 mg TRP per 100 g of chicken breast); moreover, TRP absorption rates differ significantly if consumed alongside other AAs.115

The conclusion is that normal, moderate consumption of TRP in meals is considered safe for MAOI patients.

The MAOI Diet—Partim Specialis

Introduction

This Partim Specialis of the Prescriber’s guide to the MAOI diet builds on the overarching principles set out in the Partim Generalis. The potentially relevant dietary interaction mechanisms have been discussed in sufficient detail in the preceding sections, and are preferably consulted in conjunction with the specialised food science data listed hereunder; read as such, this article presents a cohesive and comprehensive whole, in which ‘the MAOI diet’ is (finally) fully demystified.

Whilst the previously outlined considerations are thus not repeated in full, some of the most salient points are briefly restated where appropriate.

The following abbreviations are maintained:

Monoamine oxidase inhibitors (MAOIs): phenelzine (PLZ), tranylcypromine (TCP), isocarboxazid (ISO).

Biogenic amines (BAs): tyramine (TYR), histamine (HA), dopamine (DA).

Amino acids (AAs): levodopa (L-dopa), L-tryptophan (TRP).

Blood pressure (BP).

The subsequent discussions on food science data will focus on TYR. The other BAs of some relevance (HA, DA), and the AA L-dopa are mentioned only when such is pertinent, i.e., in some specific food sections. TRP is not commented on, as potential interactions are not likely to be significant.

Food Safety Standards and Biogenic Amines (BAs)

Fresh, unfermented foods that are handled hygienically during production and storage (e.g., refrigerated at ≤4°C) are likely to have low (or no) BA levels, and are safe to consume as part of a normal diet.

Many food production processes now make use of special starter-cultures that are aimed at minimizing BA accumulation.116118 Additionally, the increased (control on) hygiene and production standards worldwide119 (e.g., the extensive monitoring procedures in regulations by the European Union)120 have greatly contributed, and continue to do so, in reducing food-borne BA levels.21,121,122 That is why consulting recent food science data is so important.

Tyramine (TYR): A Tale of Fermented Foods and Spoiled Appetites

TYR is the most hazardous BA for MAOI patients, and its dietary intake should be significantly reduced. TYR’s formation in foodstuffs requires (a) the presence of the AA tyrosine, which is then (b) converted to TYR via microbial decarboxylation.123,124 This process may be the result of either the deliberate use of (some) fermentation processes, or of the indeliberate failure to maintain appropriate hygiene, production, and/or storage standards.

Cheeses

The TYR pressor response is also known, more colloquially, as the ‘cheese effect’. A brief historical excursion may frame the discussion; it can explain why ‘hypertensive crises’ were comparatively commonplace (although still relatively rare) ‘back then’, and why that is no longer so. This brings us back to the olden days of psychopharmacology (1950s), and to the ‘serendipitous’ discovery of the antidepressant (or ‘psychic energizing’)125 action of iproniazid, an antitubercular drug that was also, later, found to inhibit MAO.126 This also brings us back to the seminal research by Blackwell et al. (1960s), who first described the cause–effect relationship with TYR, which was/is richly present in some cheeses,127 such as cheddar (TYR levels of 3500 mg/kg were found in cheddar samples by Bullock and Irvine, 1956).128 It is a testament to their impressive foresight and pharmacological prowess that these publications have withstood the test of time, and remain of striking relevance even today.65,94,129136

General Overview

Data from modern-day food science indicate that many (commercial) cheeses now have comparatively low TYR levels (e.g., <20 mg/kg), whether they are hard, semi-hard, acid-curd style, or soft.31,33,137140 Some cheeses (e.g., matured varieties)141 do still have high TYR levels (e.g., some acid-curd cheeses: ≥335 mg/kg TYR)21, with (typically) more TYR near the rind than in the core.142 Matured (typically for 3–6 months or more) and/or ‘artisanal’ cheeses will contain higher TYR levels than their ‘commercial’ counterparts.143

Mayer and Fiechter (2018) reported findings from 150 cheeses; they observed: <5 mg/kg TYR in 13 samples of extra-hard cheeses; mean TYR levels of ∼100 mg/kg in 14 samples of hard cheeses; <100 mg/kg TYR in 31 samples of blue-veined cheeses (with many <50 mg/kg TYR); mean TYR levels of ∼152 mg/kg in 14 samples of semi-hard cheeses; <7 mg/kg TYR in 12 samples of mould-ripened soft cheeses; ∼272 mg/kg TYR in 18 samples of smear-ripened cheeses; mean TYR levels of ∼157 mg/kg in 48 samples of acid-curd cheeses (with high variance: max. TYR levels of 1597 mg/kg).144 Spizzirri et al. reviewed 40 samples of hard-ripened, ripened, and unripened cheese styles: all had ≤150 mg/kg TYR.139

There are many different cheese styles; they are not all discussed here. The following subsections are ordered, for the most part, in accordance with the classification system presented by Almena-Aliste et al.145 Some cheese styles (and indeed, some research set-ups) defy such rigorous classification, and may come in a range of textures, from ‘fresh’ to ‘hard’, depending in part on their maturation status. The following categories are thus merely indicative, and present a broad-sweep overview of TYR levels in some prominent cheese styles.

Fresh Cheeses

Fresh, non-matured (i.e., unripened/unaged) cheese styles (e.g., fresh cheese, mascarpone, ricotta, cottage cheese, bocconcini) are likely to have low TYR levels, unless stored at unhygienic temperatures.146 Spizzirri et al. found undetectable TYR levels in 6 samples of robiola, ricotta, and mozzarella.139 Novella-Rodriguez et al. found max. TYR levels of 0.6 mg/kg in 20 such samples.147 Spizziri et al. also found TYR levels of <5 mg/kg in 3 fresh goat cheese samples, and undetectable TYR levels in a whey cheese sample (Ricotta Romana).139

Soft and Semi-Soft Cheeses

Brie and Camembert are typical examples of soft-ripened, ‘bloomy rind’ cheeses; these styles are made with surface moulds, are typically aged for several (e.g., 3–5) weeks before release, and are expected to have comparatively low TYR levels. Mayer et al. looked at 5 samples (from Austria, Denmark, and France), and found TYR levels of ≤5 mg/kg;33 similarly, Bonczar et al.148 found ≤6 mg/kg TYR (3 samples). In some older reports (1960s), notably higher TYR levels (∼100 mg/kg) were reported;149,150 poor production and/or storage standards, or faulty assays are possible explanations. By contrast, Kosikowski (1950s) reported low/undetectable TYR levels.127 Colonna and Adda (1976) reviewed 20 samples of French Camembert, finding TYR levels of ∼100 mg/kg in many samples—but there was a wide variance (max. 1800 mg/kg TYR).151 De Vuyst et al. (1976) found TYR levels of 0–400 mg/kg in various Brie samples, with lower TYR levels (max. 20 mg/kg) in Camembert samples.152 Voight et al. (1974) found TYR levels from 0–260 mg/kg in various Brie samples.153

Blue cheeses are made with internal moulds. Roquefort is an example of a blue-veined, sheep milk cheese; Mayer et al. examined 4 such samples, and found no TYR.33 Komprda et al. tested various samples of Czech blue cheeses, establishing mean (380 mg/kg) and median (289 mg/kg) TYR levels, with a wide variance (10–875 mg/kg TYR).154 Novella-Rodriguez et al. found a wide range of TYR levels (0–1585 mg/kg) in 20 samples of blue cheeses.147

Smear-ripened cheeses are soft, and come in washed- and unwashed-rind styles; BA levels in the unwashed varieties are significantly higher: Samková et al. examined 75 samples of various smear-ripened cheeses (aged ∼21 days); they found mean TYR levels of 1.7 mg/kg in 30 washed-rind samples, and mean TYR levels of 137 mg/kg (with a wide range of 17.5–469 mg/kg TYR) in 45 unwashed-rind samples.155 Pleva et al. tested 6 samples of smear-ripened cheeses, and found TYR levels ranging from ∼177–1200 mg/kg).156

Valsamaki et al. reviewed various Feta samples, a ‘brined’ (or ‘pickled’) cheese, finding variable TYR levels that increased with maturation (0 mg/kg TYR at day 1; 246 mg/kg TYR at day 120)157—note that, throughout the maturation process, these cheeses develop from ‘soft’ to ‘hard’.

Pleva et al. established TYR levels for various soft, mould-ripened cheeses: 9 white-veined samples (TYR levels of 9.5–40 mg/kg), and 6 blue-veined samples (TYR levels of ∼71–231 mg/kg).156

Other Cheeses

Hard Cheeses

Spizziri et al. found that Parmigiano Reggiano samples (aged 24–30 months) had 20–150 mg/kg TYR (5 samples), and that Grano Padano samples (aged 12–22 months) had <133 mg/kg TYR (5 samples).139 Schirone et al. reviewed a variety of Pecorino cheeses from various regions in Italy. Some of these are ‘artisan’ type cheeses, and TYR levels may vary widely (more ‘typical’ values are 45–475 mg/kg TYR, but one sample had ∼1300 mg/kg TYR).143 Rea et al. reviewed various cheddar samples made with 6 different enterococci strains (TYR levels of <50 mg/kg after 4 weeks, and <200 mg/kg after 36 weeks).158 These results align with older findings by Tarjan and Janossy (1978),159 who reported TYR levels of 70–210 mg/kg (3 samples). Variable, and sometimes lower TYR levels may be found (e.g., Bonzcar et al. found ≤10 mg/kg TYR in some samples).148

Komprda et al. tested various Dutch (semi-)hard cheeses: most samples had TYR levels of <50 mg/kg (max. 250 mg/kg TYR).160,161 Bunkova et al. reviewed Edam-style cheeses, noting that: ‘Optimum ripening time of these products is 6–10 weeks, usually at a temperature of 10–14 °C. However, nowadays, young cheeses (2–4 weeks old) are delivered to retail by many producers for economic reasons.’138 They found that TYR levels increased in approximately linear fashion during maturation and storage, from 60 mg/kg after 60 days, to max. 120 mg/kg after 100 days in the outer layer, or ‘rind’, and ∼70 mg/kg TYR closer to the core. Spizzirri et al. tested various Gruyere samples, finding TYR levels of <100 mg/kg; they also tested various Emmental samples, finding TYR levels of ∼16mg/kg.139

Novella-Rodriguez et al. found a wide range of TYR levels when they examined 40 samples of hard-ripened cheese, of which 20 were made from raw milk (∼0–302 mg/kg TYR), and 20 were made from pasteurized milk (∼0–164 mg/kg TYR).147

Ripened goat cheese may contain variable TYR levels: Spizzirri et al. found 0–12 mg/kg TYR in 3 samples;139 Novella-Rodriguez et al. established increasing TYR levels following ripening of goat cheeses (0 mg/kg at day 1, ∼25 mg/kg after 30 days, ∼55 mg/kg after 60 days, and ∼70 mg/kg after 90 days)162—but higher TYR levels may occur in some samples (e.g., Bonnetta et al. found an Italian goat cheese with 2000 mg/kg TYR).163

Fiechter et al. reviewed 47 samples of Austrian ripened acid-curd (sour milk) style cheeses, finding a wide variance of TYR levels (median TYR: 30 mg/kg; 95% quantile at 469 mg/kg TYR; max. 2000 mg/kg TYR in a sample of Ennstaler Steirerkäse with crumble texture).137

Processed Cheeses

Many processed cheeses are expected to have low TYR levels: Ibrahim et al. analysed 45 samples (made from a variety of cheese types), and found mean TYR levels of ∼200 mg/kg for cheddar styles, and mean TYR levels of 100 mg/kg for Gouda styles. Some samples from Egyptian retail outlets (temperature and shelf-life unclear) had higher TYR levels (max. 800 mg/kg).164

Cheese Spreads

TYR levels in cheese spreads depend on the cheese selection: whereas some commercial products may have little to no TYR, some higher-quality cheese spreads (which may be made from vintage cheeses) may be high in TYR (e.g., a Parmareggio sample tested at 40 mg/kg TYR).139

Meat Products

Fresh Meat Products

While fresh and frozen meat products have low BA levels, they may accumulate in meat products that are not fresh (and are therefore subject to decomposition by micro-organisms).165169 It is essential to maintain proper storage temperatures (≤4°C): chilled meats that are stored for a limited time tend to have TYR levels <10 mg/kg.165,170,171 Triki et al. reviewed TYR levels of various meats (pork, lamb, turkey, chicken, beef) that were stored for 0–10 days at 2°C: for all meats, TYR levels were ≤0.70 mg/kg at day 0, and ≤1.12 mg/kg at day 3; TYR levels then rose precipitously by days 6 (≤28.5 mg/kg) and 10 (≤35.5 mg/kg).172

Poultry

Various poultry meats (chicken, turkey, duck) were found, by several research groups, to have (very) low TYR levels173177 (e.g., one sample of duck had no detectable TYR).176 Long storage times may result in TYR accumulations178181 (e.g., chicken stored at 4 ± 1°C was found to have 3 mg/kg TYR after 1 day; after 20 days, TYR levels had increased to 15 mg/kg).173 Improperly stored or spoiled meats are likely to have high BA levels (e.g., a chicken sample with 222 mg/kg TYR).182

Beef and Pork

Typical (‘commercial-grade’) beef is not usually aged, and typical TYR levels may be <10 mg/kg (e.g., Galgano et al. measured TYR levels of 7 mg/kg after 8 days of storage at 4°C).171 ‘Restaurant-quality’ beef can have significant TYR levels when stored above 0°C: when stored at 4°C for 21 days, TYR levels of 60 mg/kg were found; after 36 days, they had increased to 120 mg/kg TYR.168 Beef that was stored at −18°C for 178 days was found to contain <4 mg/kg TYR.170 Pork and fresh pork products are likely to have low (sometimes undetectable) TYR levels.183185

Minced and Ground Meats

Accurate TYR levels for minced and ground meats (e.g., hamburgers) cannot be provided due to the unpredictability of the preparation process: contaminant bacteria may find their way into the mix (as the mince has a large surface area), and the procured meat products may be stored sub-optimally. While one assay by Durlu-Ozkaya et al. found low TYR levels (<3 mg/kg),186 it is unclear how reproducible these findings are. It is a heartening sign that there are no case reports known to us indicating hypertension in MAOI patients following hamburger consumption—but caution and portion control remain warranted. A similar observation can be made with relation to other processed meat products of uncertain make (e.g., chicken nuggets, which have been implicated in hypertensive reactions in MAOI patients),187 for which BA levels cannot be reliably estimated.

Offal Meats

Fresh offal (organ) meats are unlikely to contain significant TYR: various samples of fresh kidneys, livers, duck giblets, etc. were all found to contain low TYR levels.176,188190 The fact that case reports of hypertensive reactions to such meats exist,191,192 appears to indicate, once more, the importance of proper production and storage practices193 (and of avoiding unreasonably large portions).

Meat Pâtés

Providing accurate TYR levels for meat pâtés as a general category is not possible, much like is the case with minced and ground meats. The reasoning is that fresh meats have little to no TYR, but once processed (and possibly contaminated with various bacteria), the product becomes an ideal culture medium; i.e., any laxity in hygienic preparation, storage time, or temperature (≤4°C is essential) will result in a steady increase in TYR levels. Therefore, in contaminated and/or poorly stored products, TYR may rapidly accumulate (e.g., 100–500 mg/kg TYR after 1–2 weeks).194

Preserved Meat Products

Dry-Cured Meats

Dry-cured meat products (e.g., Parma ham, pastirma, jamon, prosciutto, coppa) that have been properly handled and stored may have comparatively low TYR levels195 (e.g., Lorenzo et al. found TYR levels of 5–10 mg/kg in lacón, a dry-cured Spanish meat product)196—but there are numerous exceptions; e.g., Salchichón (280 mg/kg TYR), dry-cured ham (104 mg/kg TYR),197 and various salamis (20 commercial samples ranged from 0–355 mg/kg TYR, and 0–505 mg/kg HA).198

Fermented Sausages

TYR levels in fermented sausages (and similar products) depend heavily on the hygienic quality of the meat used, and on the strains of bacteria involved; those produced with frozen meat (low temperature processing) may well have ≤100 mg/kg TYR (owing also to the widespread usage of standardized starter-cultures,199 which may have little/no AA decarboxylase activity—resulting in lower BA levels).200205

Suzzi and Gardino reviewed 20 studies on fermented sausages from around Europe, and found that TYR levels were usually ≤200 mg/kg (mean values), but that some samples contained significantly more TYR (>600 mg/kg).206 Similarly, Ruiz-Cappilas and Jimenez-Colmenero identified some higher TYR samples,195 and so did Bover-Cid et al.: they examined various samples of Spanish fermented sausages (Chorizo, Fuet, Sobrasada, and Salchichón), finding TYR levels of ≤600 mg/kg in some sausages, with mean values of about 200 mg/kg TYR.207 Various other samples (some artisanal, some industrial) were found to have TYR levels of ≤270 mg/kg.206,208 Papavergou et al. tested 50 samples of dry fermented sausages sold in Greece; they were found to contain mean TYR levels of 100 mg/kg, and max. TYR levels of 500 mg/kg.209

Hygiene standards continue to improve: more recent surveys tend to find lower BA levels:202,210,211 e.g., Latorre-Moratalla et al. (2012) tested fermented sausage samples, and found average TYR levels of 150 mg/kg (with max. <200 mg/kg TYR).201

Fish Products

Fresh Fish

BA levels in fish are dependent, to a substantial degree, on the freshness of the product and on the use of proper, low-temperature handling and storage methods;212 as such, quality control and screening of imported fish produce continue to be powerful forces for improving hygiene standards worldwide.175,213 Whilst all BA levels (e.g., TYR and HA) may be significantly increased if such conditions are not maintained, it is important to note that BA levels do not necessarily increase simultaneously and proportionally: fish spoilage can result in greatly elevated HA levels,214 without the occurrence of correspondingly significant increases in TYR levels.215 To further illustrate: Özogul and Özogula tested TYR levels of fresh, ice-stored (∼2°C) herring, and found <5 mg/kg; whilst the specific storage conditions of these samples varied a little, HA levels could reach 400 mg/kg whilst TYR levels remained comparatively low.216

Fresh, properly handled (raw or processed) seafood products are expected to have low TYR levels:217 various such samples were found to have 1–5 mg/kg TYR.218,219 Whole and filleted trout that had been kept on ice for up to 18 days had TYR levels of ≤7 mg/kg.220,221 Emborg et al. tested various samples of fresh (frozen) salmon, and established max. TYR levels of <25 mg/kg by the end of shelf life (14–21 days), whereas TYR levels of thawed salmon had increased to just below 70 mg/kg by the end of shelf life (21–34 days).218,222 Kulawik et al. found TYR levels from 10–14 mg/kg in 6 supermarket-bought ready-to-eat-sushi samples.223 The following fish samples (freshness unknown) have tested high in TYR (>100 mg/kg): amberjack, anchovy, cod, mackerel, tuna.182

With respect to containing HA levels, Abajay et al. further demonstrated the importance of storage time and conditions: they tested 2 samples of market-bought yellowfin tuna; sample 1 was immediately gutted and subjected to HA level analyses for 18 h (HA levels of 3.18 mg/kg), and sample 2 was gutted 12 h after purchase and subjected to the same storage conditions (HA levels of 6289 mg/kg).224

As previously outlined—see supra, ‘Histamine (HA)’—the ingestion of high HA foods may cause Scombroidosis (HA poisoning);24,217,225 this is a form of food-borne intoxication,226 on which Visciano et al. state that the ‘consumption of meals with HA concentrations of 8–40 mg can cause only slight intoxication, while values of 40–100 mg or higher than 100 mg are associated with intermediate and severe intoxication, respectively’.227

Many regulations in various jurisdictions are thus aimed at limiting HA levels:227,228 e.g., the US Food and Drug Administration (FDA) considers fishery products that have <50 mg/kg HA to be ‘decomposed’, and products that have <500 mg/kg HA to be a ‘health hazard’;226 EU regulations set HA standards at 200 mg/kg for various ‘fishery products from fish species associated with a high amount of histidine’, and at 400 mg/kg HA for ‘fishery products which have undergone enzyme maturation treatment in brine, manufactured from fish species associated with a high amount of histidine’.229

Patients who take a hydrazine-derivative MAOI (PLZ, ISO) are advised to exercise additional care with regard to HA intake; this is less of a concern for TCP patients (see supra, ‘Histamine (HA)’).

Other Fish Products

Cured Fish Products

The preservation of fish products via curing (instead of canning or refrigerating) is of great cultural and historical significance, and is still widely done today; fish curing is a broad term that comprises various preservation methods: smoking, drying, marinating, pickling, salting, fermenting, as well as combination methods.230 Variable BA levels are likely to occur, and may be high in some products (e.g., fermented seafoods such as surströmming, rakfisk, and kæstur hákarl);231 an exhaustive list cannot be provided. Test results from some samples are listed hereunder.

Smoked salmon (dry-salted, sliced, vacuum-packed) was found to contain no TYR after 4 weeks of storage (as sterile, cold-smoked salmon blocks); the specific storage conditions were as follows: 9 days at 4°C, and 19 days at 8°C.232 Jørgensen et al. tested various cold-smoked salmon samples, and found TYR levels of <20 mg/kg233—but Köse et al. found samples that had up to 470 mg/kg TYR.234

Gravlax is made from dry-salted fish filets (salmon, mackerel, trout, herring); Wiernasz et al. tested 7 samples of salmon gravlax that had been treated with various bioprotective bacterial cultures, and found max. TYR levels of ≤25 mg/kg after 21 days of storage.235 Periago et al. found TYR levels of 90 mg/kg in samples of dried and salted tuna roe.236

Canned Fish Products

Veciana-Nogues et al. tested several canned tuna samples, and found TYR levels of ≤10 mg/kg for most samples;237 canned, pickled herring (3 samples) had <10 mg/kg TYR and <3 mg/kg HA; some samples of semi-preserved anchovies contained up to 70 mg/kg TYR and 220 mg/kg HA.238 High HA levels were also found in some canned fish samples, with one sample reaching 1000 mg/kg HA.239,240

Fermented Cereals

General Overview

There are a great many fermented cereal products available worldwide. Such products can be made from various cereals (e.g., wheat, maize, barley, oat, barley, rye, rice, millet, sorghum); they include boza, idli, injera, kumru, khambir, uji, kunu, dhokla, tarhana—and many more varieties exist.241 They may have significant BA levels;242 e.g., Yeğin and Üren tested 11 samples of boza, and found a range of TYR levels of 13–65 mg/kg;243 Özdestan and Üren tested 20 samples of tarhana, and found a range of TYR levels of 50–100 mg/kg.244 Data on BA levels in many fermented cereals remain to be collected; caution is warranted.

Sourdough Bread

Sourdough bread is produced with the use of bacterial activity in the starter-culture for making the dough. BA levels are lower when standardised starter-cultures (with minimal decarboxylase activity) are used, as is now generally the case with commercial production.118 However, artisan-producers may utilise cultures with greater decarboxylase activity. Therefore, their products may sometimes contain significant TYR levels (e.g., Rizzello et al. (2010) found TYR levels of ∼700 mg/kg in sourdough fermented wheat germ;245 Mannino et al. (2022) tested 6 sourdough bread samples—3 of which were made in a bakery (<0.4 mg/kg TYR), and 3 of which were home-made (wide range of 5–120 mg/kg TYR).246 Özdestan et al. tested 10 samples of kumru (a similar Turkish food) from different manufacturers, and found TYR levels <5 mg/kg.242

Marmite and Related Products

Marmite and related products (Bovril, Promite, Vegemite, etc.) are made from brewers’ yeast extract, which may contain wheat, barley, and rye. These products are considered high in BA content: recent TYR level readings range from 322 mg/kg247 to ∼650 mg/kg248—both numbers are significantly lower than Blackwell et al.’s earlier (1960s) estimate of ∼1500 mg/kg TYR; this may represent improvements in production technique, or measurement inaccuracies.94,135,136 There is a relative paucity of recent data pertaining to BA level measurements in these products.

Soups and Sauces

Soy Sauces and Soups

Various soy-derived products (those not previously discussed), such as miso soups, and soy sauces, are expected to have elevated BA levels,249,250 similar to processed soy foods (see infra). Miso has been implicated in hypertensive reactions in MAOI patients251—but this case report is from 1987; modern hygiene and production standards may have contributed in reducing BA levels in many (but not all) such preparations.250,252

Yongmeia et al. examined BA levels in 40 samples of Chinese soy sauces, finding a wide range of TYR (8.5–600 mg/l) and HA levels (0–300 mg/l).253 Similar results were observed by Stute et al., who found one soy sauce sample that had 5250 mg/l TYR.254 Guidi and Gloria tested TYR levels in 42 such samples: in 12 samples, TYR was <29 mg/l; in 4 samples, TYR was between 30–99 mg/l; in 25 samples, TYR was between 100–499 mg/l; in 1 sample, TYR was between 500–799 mg/l.249 Ibe et al. reviewed TYR levels in the moromi mash used in some soy sauce preparations; they found max. TYR levels of 940 mg/l, with many samples ranging from 10–200 mg/l TYR.255

Cho et al. tested various samples of miso (all ≤25 mg/l TYR) and soy sauces (all <50 mg/kg TYR).250 Byun and Mah tested 22 miso samples, and found a wide range of TYR levels (from low/virtually none to >70 mg/kg); as previously discussed, this may in part be explained by varying hygiene standards.256 Kung et al. tested 40 misu samples, and found that all contained <50 mg/l TYR.257

Fish Sauces

Fish sauces may contain various seafoods (including anchovies) that have been allowed to ferment for extended periods; names include: budu (Malaysia), patis (Philippines), ngapi (Burma), ishiru (Japan), yeesu (China), etc. BA levels for all these varieties cannot be listed (and may not yet be available).23,254,258

Cho et al. tested BA levels in Korean fish sauces (made from a variety of seafoods, including scallop, squid, etc.) and found average TYR levels of ∼350 mg/kg TYR, with one (anchovy-based) sample testing at 600 mg/kg TYR.250 Stute et al. tested 45 samples of commercial fish sauces from the Far East: many samples had TYR levels ≤250 mg/kg; the highest TYR level found was 588 mg/kg.254 Saaid et al. tested various samples of budu and cincalok (Malaysian appetizers), and found TYR levels of ≤450 mg/kg.258 Naila et al. tested 28 samples of rihaakuru, a fish paste condiment, and found TYR levels of 0–93 mg/kg, and HA levels of 0–5100 mg/kg.259

Similar products, such as Worcestershires sauces, are available in many varieties from many producers; typical preparations are fermented, and may contain hydrolyzed vegetable protein, soy sauce, or anchovies.260 There are no data available on TYR levels; caution (or outright avoidance)261 is thus warranted.

Bouillon-based Broths

Typical bouillon cube-based broths and soups (e.g., meat or soup bases and extracts made with chicken, beef, or vegetable bouillon) are expected to have low (or no) TYR, as these products are not usually fermented.262 Populin et al. tested various broths (homemade or canned products from the market), soups (ready-to-eat soups, condensed soups, and creams), soup bases (bouillon cubes, pastes, and granulated powders), sauces, and salad dressings from the European and US markets; they found increased levels of the BA putrescine in products that contained monosodium glutamate (MSG), but TYR levels remained at ≤10 mg/kg in all samples.247

Vegetables

General Overview

Fresh vegetables typically have comparatively low BA levels; Moret et al. tested various typical vegetables (e.g., lettuce, onion, carrot), and found TYR levels of ≤12 mg/kg (only spinach, broad bean, potato, and arugula tested at 7–12 mg/kg TYR; the other samples tested at ≤3 mg/kg TYR)263—but spoilage can cause increased BA levels (e.g., 8-fold increases in pre-packaged salad/leafy vegetable mixes after 6 days of storage).262

Glória compiled TYR levels from various research studies; the following all tested ≤5 mg/kg TYR: broccoli, cassava (cooked), cauliflower, collard greens, lettuce, parsley, fresh spinach.264 Similarly low TYR levels were found in asparagus, carrot, chard, sweet corn,37 and potato.265 Higher TYR levels were found in canned hearts of palm (≤7.8 mg/kg), spinach purée (≤10 mg/kg),264 arugula (12 mg/kg), cabbage (18.6 mg/kg);182 frozen spinach purée (mean of ∼10 mg/kg; max. of ∼32 mg/kg).266 Spinach may also have high HA levels (27.5–100 mg/kg).265,267

Plants produce a range of amines and psycho-active alkaloids (e.g., opiates, cannabis, tannins, nicotine, atropine, hyoscine, aperients, innumerable toxins); our scientific understanding of these topics is rapidly advancing263,265,266,268 (e.g., the recently emerged research on the potential effects of capsaicin and menthol on trace amine-associated receptors and transient receptor potential channels).269,270 The particular relevance of such developments in plant science for MAOI patients is at this point unclear.

Legumes

BA levels were shown to vary considerably in different germinating legume seeds, including chick peas, lupine seeds, and broad beans.262 Glória264 reviewed TYR levels from various research studies: fresh chickpea (3.7 mg/kg), germinated chickpea (12.1 mg/kg), fresh broad bean (6.2 mg/kg), germinated broad bean (13.6 mg/kg), fresh lupine (7.8 mg/kg), germinated lupine (12.2 mg/kg). Variable TYR levels were found in 12 samples of green beans (0–10 mg/kg), and in frozen peas (≤16.5 mg/kg).37 Low/undetectable TYR levels were found in various beansprout samples,264 yellow/purple/white bean, peanut (7 samples), pea (9 samples) chickpea (4 samples), lentil (7 samples).37

Some legumes contain significant amounts of L-dopa in some tissues, at some stages of growth; they include Vicia faba L. varieties (fava/faba beans or broad beans),271 and Mucuna pruriens (cowhage or itching powder).272278

Fava Beans

Fava beans were found to contain TYR levels of ∼10 mg/kg (various samples).263 Topal and Bozoğlu measured L-Dopa levels272 in the leaves (<34 mg/kg), flowers (<97 mg/kg), and fresh pods (<53 mg/kg) of 20 different fava bean genotypes.279 Brown et al. noted the presence of significant DA levels in the pods, but not so much in the seeds.280

Soy Bean Products

Fresh soy products

Soy bean products tend to be rich in protein. Soy beans themselves have low/undetectable TYR levels,264 but they are not eaten raw. Fresh soy products trend towards low TYR levels,281 assuming proper handling and storage conditions are maintained282—such is evidenced by Yue et al. who tested 6 samples of firm (unprocessed) tofu, and found high TYR levels in 2 samples (31.5 mg/kg and 185 mg/kg), and low TYR levels (<2.5 mg/kg) in the other 4 samples.283 Sánchez-Pérez et al. report findings of undetectable TYR levels in 6 fresh tofu samples.37

Processed Soy Products

Processed soy bean products, some of which may be fermented (e.g., natto,284,285 sufu),286 are more prone to having significant BA (TYR and/or HA) levels (e.g., some stinky tofu samples were found by Gu et al. to have ≤170 mg/kg TYR;287 some sufu samples were found by Guan et al. to have low or undetectable TYR levels, whereas some other such samples had TYR levels ranging from 10–470 mg/kg).288 Kung et al. tested various Taiwanese sufu samples (12 white sufu samples, and 10 brown sufu samples; the TYR levels were recorded, respectively, at ≤40 mg/kg, and at ≤64 mg/kg).289 Soy bean pastes (Doenjang) were analyzed (23 samples) by Shukla et al.: some had low undetectable TYR levels—but several samples contained >1000 mg/kg TYR.290 A full list of soy products (which exist in abundant varieties, both fresh and processed) cannot be provided.

Fermented Vegetables

Vegetables that are most commonly fermented include ‘cabbage (sauerkraut, kimchi), cucumbers, onions, carrots, and garlic’;291 TYR may accumulate to significant levels in such products.292 Świder et al. tested various fermented vegetables (several samples each), and reported the following TYR levels (mg/kg):, broccoli (47–182), brussel sprout (120–204), radish (15–36), champignon (0.5–85), garlic (1–22), white cabbage (29–105), red cabbage (0–112), kimchi (1.2–99), cauliflower (0.3–136), beetroot (1–48), carrot (0–61), sunchoke (0–1.4).292 Kalac and Glória reviewed over 100 sauerkraut samples from 7 different countries; many had TYR levels of <200 mg/kg, but some samples had 400–900 mg/kg TYR.293 Kimchi, may also have significant TYR:294 Cho et al. tested various samples (max. TYR level found was 120 mg/kg).250 Kirschbaum et al. tested 5 samples of sauerkraut juice, and found TYR levels of ∼30–70 mg/l.295

Fruits

General Overview

Most fresh fruits have low TYR levels (e.g., undetectable TYR in apple,182 peach, pineapple, cherry, grapefruit, kiwi, lemon, green/red pepper);37 Glória264 reviewed BA levels of various fruits, and recorded TYR levels ≤5 mg/kg for the following samples: banana (green, ripe, overripe), fresh tomato, eggplant (whole, seed, pulp), red plum, strawberry, capers, jilo. Similarly low TYR levels were found in samples of courgette, cucumber, pumpkin.37 The following fruit samples had higher TYR levels: raspberry (12.8–92.5 mg/kg), eggplant peel (141 mg/kg), tomato paste (≤32 mg/kg), ripe banana pulp (∼50 mg/kg). Other reports found higher TYR levels in banana (23.5 mg/kg),182 mandarin (13 samples: 0–5.8 mg/kg), tomato (0–6.4 mg/kg in 53 samples), plum (2 samples: 1–7 mg/kg).37 García-García et al. found undetectable TYR levels in canned ripe olives; they also tested several other packed (pickled, unfermented) products: capers, caperberries, cucumbers all had TYR levels of <4.5 mg/kg.296

Avocados

There is a case report of elevated BP in a TCP patient who had consumed 4 avocados (possibly ripened) and an undisclosed amount of guacamole.297 Whilst some reports estimate TYR levels in avocados to be ∼23 mg/kg,264 others offer lower estimates (0.5–5.5 mg/kg TYR).37 On the whole, there is a paucity of recent BA data; additionally, ripening/spoilage may cause considerable increases—moderation in consumption patterns is therefore advised.

Bananas

Borges et al. reported in their extensive and recent study (2019) of many banana-varieties (including plantains), that various BAs, including TYR, HA, DA, spermidine, and spermine all decreased during the ripening process in most genotypes.298 They noted, additionally, that TYR levels in the pulp were remarkably consistent across different genotypes (∼100 mg/kg, dry weight); they observed a wider variance of TYR levels in the peel (100–300 mg/kg, dry weight).

The first report relating banana consumption to DA-ergic effects stems from 1958.299 Large amounts of banana can increase plasma DA concentrations.300 As with other plants, BA levels will vary widely, depending on the stage of growth, on which part of the plant is measured, on maturation and ripeness status, etc. BA levels may be higher in the skin than in the pulp.101,301304 Borges et al. tested various banana samples, and found in the pulp: DA levels of 300–400 mg/kg, and L-dopa levels of 50–70 mg/kg (dry weight); and in the peel: DA levels of ≤6200 mg/kg, and L-dopa levels of ≤70 mg/kg (dry weight).298 Older data largely concurs: findings include DA levels of ≤400 mg/kg in the pulp, and ≤1500 mg/kg in the skin.265,301,305

Peppers

Kang et al. reported on TYR levels in blended, freeze-dried (-80°C) bell pepper (∼300 mg/kg, dry weight) and green hot peppers (∼145 mg/kg, dry weight).268

Fermented Fruits

Świder et al. reported the following TYR levels in fermented fruits (several samples): cucumber: 28–87 mg/kg, pumpkin: 20–112 mg/kg, tomato: 0.5–24 mg/kg, pepper: 15–23 mg/kg, and olive: 1.7–4 mg/kg.292 Fermented, minced peppers were found to contain TYR levels of ≤2.5 mg/kg after 10–12 weeks of storage.306 Tofalo et al. found no TYR in 7 varieties of fermented table olives.307

Varia

There remain foods (fruit-based, in this case) that may bring about unexpected effects, e.g., a patient reported to PsychoTropical Research that she noticed significant BP increases after consuming (undisclosed amounts of) quince paste—a plausible explanatory mechanism may be that this food product acts as an inhibitor of DA reuptake.308

Other Foods

Dairy Products (other than cheese)

Fresh milk was found to have undetectable TYR levels.309 This does not hold true for fermented milk products, such as kefir, which may have variable TYR levels (0–13 mg/l in 10 samples).310 Some fermented milk products (buttermilk, most yoghurts) are expected to have low BA levels, whereas some others (e.g., kumis) have comparatively high total BA levels (15.3 mg/l).140 Novella-Rodriguez et al. detected no TYR in 5 yoghurt samples;146 Cho et al. tested 8 Korean yoghurt samples, and found max. 4 mg/kg TYR).250 Yılmaz and Gökmen tested 7 samples made with different bacterial starter cultures, and found TYR levels ranging from ∼0–31.5 mg/kg.311 More exotic products may have higher TYR levels (e.g., yoghurt made from fermented yak-milk tested at 900 mg/kg TYR).312

Condiments

Kalač et al. tested 24 samples of ketchup, and found mean TYR levels of 33.6 mg/kg, and max. TYR levels of 149 mg/kg.266 Sánchez-Pérez et al. found undetectable TYR levels in 3 ketchup samples.37

Mushrooms

Jabłońska-Ryś et al. tested various (un)processed mushrooms species, and found high TYR levels (≤3000 mg/kg) in several dried or pickled samples of bolete and jelly ear mushrooms, and undetectable TYR levels in 6 common raw mushrooms—but significant variability in BA levels may be expected in different mushroom species.313

Nuts

Undetectable TYR levels were found in almond, pine nut, pistachio,182 chestnut, sunflower seed; additionally, 9 samples of hazelnut were tested (0–2.6 mg/kg TYR).37

Chocolate

Restuccia et al. reported BA levels of 48 cocoa-based products (white/milk/dark chocolate, cocoa powder, chocolate spread/syrup, etc.); none of the samples had TYR levels ≥35 mg/kg, with many being <10 mg/kg.314 Other studies found lower TYR levels (≤3 mg/kg) in various samples of dark/milk/white/85% cocoa chocolate.265,315318

Compound Foods (e.g., pizza)

TYR levels in compound foods can vary significantly (i.e., it depends on what you put on it). Shulman and Walker (1999) concluded that most pizzas from ‘large chain commercial outlets’ (which tend to use either non-matured, or commercial processed cheese) are safe.261 Sensible caution remains appropriate: some gourmet pizzas may use cheeses higher in TYR. Also, salami toppings may add to total TYR content.

Varia

Many plant-derived substances (alkaloids), e.g., various herbs and/or beverages, like coffee and tea, may contain compounds that act, in a sense, as ‘drugs’ (e.g., stimulants such as caffeine, 2-phenylethylamine, methylamine, trimethylamine).319 These substances affect everyone, but may have an exaggerated effect in MAOI patients; There is a case report of coffee-induced hypertension (unrelated to TYR) in a TCP patient.320 Such products should be consumed either in moderation, or should be avoided if they precipitate symptoms such as tremor, anxiety, jitteriness, palpitations, tachycardia, agitation, or poor sleep.

The ingestion of 400–1600 mg of monosodium glutamate (MSG) was found by Balon et al. not to elicit BP increases in TCP patients.321

Health and Sport Supplements

Substances which are allegedly efficacious in improving health and/or sports performance should be approached with some wariness: they may contain various (sometimes illegal) additives,322 some of which are potentially injurious, and some others quite useless. The commonest adulterants are serotonin reuptake inhibitors, like sibutramine (risk of serotonin toxicity), steroids, stimulants, and sildenafil (Viagra). Producers should list the ingredients—if they do not (clearly and reliably) provide such information, their supplement should not be used. If the ingredients are listed, one can follow the precepts outlined in this guide to assess whether the product is safe; caution remains warranted (e.g., low starting dose).

Alcoholic Beverages

Many alcoholic beverages may be safely consumed in moderation.248 That is because modern, hygienic production processes have, for the most part, resulted in significantly reduced BA levels—but this does not hold universally true: e.g., some home-made (‘boutique’, or ‘artisan’) wines and beers may have high BA levels still.

Note that the alcohol content of a drink does not correlate with the potential for BA formation (e.g., depending on the production process, non-alcoholic beers may also have high BA levels; this is the case for spontaneously fermented non-alcoholic beers, in which TYR levels of 31.5 mg/l have been found).323

An important reminder: TYR in liquids, certainly when taken on an empty stomach, will be much more rapidly absorbed,60,63 so that additional caution is warranted.53,324

Wines

Most wine is safe to drink in moderation. Total BA content in wines depends on several factors (including the winemaking method used, e.g., typically more BAs in red wines than in white wines—this is due, likely, to the typically greater role of malolactic fermentation in producing red wines);325 various BAs may be formed during several distinct ‘vinification stages’, e.g., during malolactic fermentation (lactic acid bacteria), during alcoholic fermentation (yeast metabolism), or during the botrytization process undergone by some wines (made from ‘noble rot’—i.e., fungi-infested grapes).326 Other factors include: climate and soil type,327,328 length of exposure to yeast lees, and the level of bacteria variety and activity (microflora complexity increases as pH does).329

Moreno-Arribas and Polo tested various aged wines (all <5 mg/l TYR).330 Mafra et al. tested 30 different wines, including aged and fortified wines (Port and Madeira), finding TYR levels ≤5 mg/l.331 Jayarajah et al. found similar TYR levels (≤3 mg/l) in various USA wines.325 Gómez-Alonso et al. tested 18 red wines and 14 white wines; all had ≤5.5 mg/l TYR.332 Rioja crianza red wines were found to have, on average, TYR levels of 5.78 mg/l.326 Ginterová et al. found TYR levels of 1.5–2.5 mg/l in 7 Czech red wine samples.333 Marcobal et al. tested 61 different Spanish wines, including aged Rioja Gran Reserva wines; they found TYR levels ranging from 0–11.32 mg/l, with only 34 of 61 wines having detectable TYR.334 Henríquez-Aedo et al. tested 60 samples of Chilean reserve varietal wines, and found TYR levels ≤6.5 mg/l.335 Hannah et al. reported on TYR levels in 12 white wines (≤6.6 mg/l), 10 red wines (≤3.8 mg/l), and 12 chiantis (≤4.7 mg/l).336

Jayarajah et al. tested various wines and sakes: all were ≤4 mg/l TYR, but HA levels were higher in some samples: ≤50 mg/l.325 Konakovsky et al. tested 100 high-quality Austrian red wines: TYR levels ranged from 1.07–10.7 mg/l (median: 3.52 mg/l); HA levels ranged from 0.52–27 mg/l (median: 7.20 mg/l).337 Other researchers tested 300 wine samples for TYR levels (all ≤5 mg/l),338,339 and 200 wine samples for HA levels (1.2 mg/l on average).340

Some wines have higher TYR levels, e.g., some Spanish red wines (≤19 mg/l).326 Hlabangana et al. tested 9 red wines (young, Crianza, Reserva), and found a wide range of TYR levels: 9–64 mg/l.341 Arrieta and Prats-Moya tested TYR levels in 7 young wines (all <10 mg/l), 3 Crianza wines (4.8–11 mg/l), and 4 Fondillón wines (6.8–18.5 mg/l).342 Preti et al. tested 60 Italian wine samples, and found 8 with TYR levels >10 mg/l.343

Vinegars

Variable TYR levels have been reported in vinegars, e.g., 15.7 mg/l in both Aceto Balsamico and Sherry vinegar, but 416 mg/l in a rice-based vinegar made with salt (and undetectable TYR in a rice-vinegar made with sucrose).295

Beers

General Overview

Over the past decades, BA levels have been significantly reduced in many commercial beers, owing largely to improvements in production and hygiene standards (leading to fewer and less impactful contaminations during the fermentation process)—but there are exceptions,344 e.g., spontaneously fermented beers;345 craft beers (from microbreweries)346 that are produced without a filtration or pasteurisation process;347 some bottled beers that have been insufficiently pasteurised, allowing for TYR and HA formation (from lactic acid bacteria activity); etc.348

BA levels can vary widely within beers of the same fermentation category: TYR levels from ∼1–37 mg/l have been reported in top-fermented beers (e.g., Kriek, Weissbier, Ale); TYR levels from ∼0.5–47 mg/l have been reported in bottom-fermented beers (Pils, Dortmunder, Lager).323 Loret et al. tested 220 top-fermented beers (some of which underwent additional bottle fermentation), and found 21 samples with HA or TYR levels >10 mg/l.345

Kalac et al. tested 195 samples of bottled or canned beers, ‘purchased from commercial outlets in Germany, Austria, Belgium, Bulgaria, Czech Republic, Denmark, Spain, France, Great Britain, Greece, The Netherlands, Ireland, Italy, Portugal, Switzerland, and the former Yugoslavia’; many had TYR levels in the range of 2–8 mg/l (mean of 7 mg/l TYR)—but several samples had more TYR (≤70 mg/l).348350 Anli et al. tested 17 Turkish domestic beers and 13 imported beers; all had TYR levels <2 mg/l.351 Kirschbaum et al. found undetectable TYR levels in 6 beer samples, and 17.5 mg/l TYR in Lambic beer.295 Bunka et al. reviewed 114 beer samples from 28 Czech breweries; they found TYR levels of <10 mg/l in 51 samples, 10–50 mg/l in 21 samples, and ∼100 mg/l in 5 samples.352 Pradenas et al. tested over 300 beer samples on the Chilean market, and found that 99% of them had TYR levels of ≤2 mg/l (max. 6 mg/l TYR).353

Tang et al. tested 18 beers (all brewed in China; some under European license); they found TYR levels of 3–5 mg/l in most samples (max. 7 mg/l TYR).354 Cortacero-Ramirez et al. found TYR levels of <9 mg/l in various Spanish beers.355 Izquierdo-Pulido et al. found mean TYR levels of 5 mg/l in 17 beer samples, and mean TYR levels of 7 mg/l in 55 other samples (max. 47 mg/l TYR); various European beers (48 samples) had ≤6 mg/l TYR; 195 beer samples from various European countries were found to have a wide range of BAs: mean TYR levels were established at 6.5 mg/l, with a high max. of 67.5 mg/l TYR.356358 A substantial TYR range was also found in Brazilian beers (0.3–37 mg/l TYR).326

Draught Beers

BA levels, including TYR and HA, are expected to be higher in beers on tap (draught beers); this may be due to bacterial contamination of the dispense lines, the taps and/or the spouts.359 Tailor et al. reviewed 98 beer samples of 79 different brands (49 bottled or canned beers; 49 beers on tap), and concluded:

‘All of the bottled beers analysed had safe tyramine concentrations (10 mg/liter; range, 0 to 3.16 mg/liter) and, thus, do not require restriction in patients receiving MAOIs. Therefore, the consumption of canned or bottled beer, including dealcoholized beer, in moderation (fewer than four bottles or cans; 1.5 litres within a 4–hour period) appears to be safe and does not require restriction in patients receiving MAOIs. Only 4 of 98 beer samples studied were found to have a dangerous (>10 mg/liter) tyramine concentration, one of which was the index beer. The tyramine concentration in these four beers ranged from 26.34 to 112.91 mg/liter. All four of these beers were tap beers produced by bottom fermentation (lagers) and brewed by a secondary fermentation process.’ … ‘Therefore, to err on the side of caution, it is recommended that patients on irreversible MAOIs avoid beers on tap.’360

Spontaneously Fermented Beers

Loret et al. tested BA levels in 42 spontaneously fermented beer samples (e.g., Lambic), and found mean TYR levels of 28 mg/l, and max. TYR levels of >60 mg/l.345 Belgian Lambic beer is an old-style, spontaneously fermented beer; it is allowed to spontaneously ferment with wild airborne yeasts in well-ventilated attic roofs (accumulating enteric, as well as lactic and acid bacteria), where it is then aged for 1–3 years.345,361 High BA levels are to be expected in such beers, e.g., TYR levels of ∼68 mg/l have been found in Lambic and Gueuze style beers.323

Traveling and Tyramine

Some holiday destinations will require heightened awareness of food hygiene issues e.g., Rabie et al. found TYR levels of 2000 mg/kg in some cheeses and fermented sausages;362 then there is fermented Yak milk,312 and the Icelandic Hákarl (fermented shark meat), etc. MAOI patients must be advised to avoid suspect foodstuffs.

Conclusion

Much of the above content is necessitated in order to update and contextualise previously promulgated misinformation. Almost all foods that may occasionally accumulate high TYR levels, like soy sauce and cheese, are highly flavoured foods that are normally used only in small quantities—precisely because high levels of some BAs are the cause of disagreeable smells and flavours associated with putridity (putrescine). Thus, many people find over-mature cheese and meat unpleasant.

Comparatively few cheeses have TYR levels above 500 mg/kg—meaning that a healthy-sized portion of such a cheese (25 g) is safe for most MAOI patients. The same holds true for many soy sauces when used in typical condiment quantities (∼10 ml).

Because BAs are also relevant for other health reasons (e.g., migraineurs), we suggest the time has come for all the fermented and matured foods itemized in this review to be required to state their TYR content as part of food labelling regulations.

Footnotes

Author Contributions

First draft and revisions: VVdE. Discussion of the first draft and preparation of the second draft: VVdE, PKG. Further reviews and comments on key points of subsequent drafts: VVdE, PKG, BBB. Final approval of manuscript: VVdE, PKG, BBB.

Disclosures

VVdE is an external research consultant for, and receives or has received consulting fees from: PsychoTropical Research, NeuraWell Therapeutics, Aristo Pharma GmbH. He has stock options in NeuraWell Therapeutics.

PKG has equity interests in, and is on the advisory board of NeuraWell Therapeutics, the company that has the patent for a modified form of tranylcypromine.

BBB has nothing to disclose.

References

  • 1.Finberg J, Gillman P. Int Rev Neurobiol . Elsevier Inc. Academic Press; 2011. Pharmacology of MAO-B inhibitors and the cheese reaction; pp. 169–190. In: Youdim M, Riederer P, eds. [DOI] [PubMed] [Google Scholar]
  • 2.Bobo WV, Richelson E. Chapter 9 – Monoamine oxidase inhibitors for treatment-resistant depression. Managing Treatment-Resistant Depression . 2022:137–166. In: Quevedo J, Riva-Posse P, Bobo WV, eds. [Google Scholar]
  • 3.Fowler JS, Logan J, Volkow ND et al. Evidence that Formulations of the Selective MAO-B Inhibitor, Selegiline, which Bypass First-Pass Metabolism, also Inhibit MAO-A in the Human Brain. Neuropsychopharmacology . 2015;40(3):650–657. doi: 10.1038/npp.2014.214. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Bied AM, Kim J, Schwartz TL. A critical appraisal of the selegiline transdermal system for major depressive disorder. Expert Rev Clin Pharmacol . 2015;8(6):673–681. doi: 10.1586/17512433.2016.1093416. [DOI] [PubMed] [Google Scholar]
  • 5.Azzaro AJ, Vandenberg CM, Blob LF et al. Tyramine pressor sensitivity during treatment with the selegiline transdermal system 6 mg/24 h in healthy subjects. J Clin Pharmacol . 2006;46(8):933–944. doi: 10.1177/0091270006289852. [DOI] [PubMed] [Google Scholar]
  • 6.Preskorn SH. Why the Transdermal Delivery of Selegiline (6 Mg/24 Hr) Obviates the Need for a Dietary Restriction on Tyramine. Journal of Psychiatric Practice® . 2006;12(3) doi: 10.1097/00131746-200605000-00006. [DOI] [PubMed] [Google Scholar]
  • 7.Melton S, Townsend CA. Selegiline Transdermal Patch (Emsam) for Major Depressive Disorder. Am Fam Physician . 2008;77(4):505–506. [Google Scholar]
  • 8.Nolen WA. Klassieke monoamineoxidaseremmers: niet geregistreerd, maar wel een plaats in de behandeling van depressies. Ned Tijdschr Geneeskd . 2003;147(40):1940–1943. [PubMed] [Google Scholar]
  • 9.Audebert C, Blint O, Monjanel-Mouterde S et al. Influence of food on the tyramine pressor effect during chronic moclobemide treatment of healthy volunteers. Eur J Clin Pharmacol . 1992;43(5):507–512. doi: 10.1007/BF02285092. [DOI] [PubMed] [Google Scholar]
  • 10.Versiani M, Nardi AE, Figueira IL, Stabl M. Tolerability of moclobemide, a new reversible inhibitor of monoamine oxidase-A, compared with other antidepressants and placebo. Acta Psychiatr Scand Suppl . 1990;360:24–28. doi: 10.1111/j.1600-0447.1990.tb05320.x. [DOI] [PubMed] [Google Scholar]
  • 11.Danquah A, Benjakul S, Simpson BK. Biogenic Amines in Foods. Food Biochemistry and Food Processing, Second Edition . 2012:820–832. In: Simpson BK, ed. [Google Scholar]
  • 12.Santos MHS. Biogenic amines: their importance in foods. Int J Food Microbiol . 1996;29(2):213–231. doi: 10.1016/0168-1605(95)00032-1. [DOI] [PubMed] [Google Scholar]
  • 13.Naila A, Flint S, Fletcher G, Bremer P, Meerdink G. Control of biogenic amines in food—existing and emerging approaches. J Food Sci . 2010;75(7):R139–50. doi: 10.1111/j.1750-3841.2010.01774.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Dabadé DS, Jacxsens L, Miclotte L, Abatih E, Devlieghere F, De Meulenaer B. Survey of multiple biogenic amines and correlation to microbiological quality and free amino acids in foods. Food Control . 2021;120:107497. [Google Scholar]
  • 15.Nuñez M, del Olmo A, Calzada J. Encyclopedia of Food and Health . Academic Press; 2016. Biogenic Amines; pp. 416–423. In: Caballero B, Finglas PM, Toldrá F, eds. [Google Scholar]
  • 16.Doeun D, Davaatseren M, Chung M-S. Biogenic amines in foods. Food Sci Biotechnol . 2017;26(6):1463–1474. doi: 10.1007/s10068-017-0239-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Feddern V, Mazzuco H, Fonseca FN, de Lima GJMM. A review on biogenic amines in food and feed: toxicological aspects, impact on health and control measures. Animal Production Science . 2019;59(4):608–618. [Google Scholar]
  • 18.Jay JM. High-Temperature Food Preservation and Characteristics of Thermophilic Microorganisms. Modern Food Microbiology . 1995:347–369. In: Jay JM, ed. Springer US. [Google Scholar]
  • 19.Omer AK, Mohammed RR, Ameen PSM, Abas ZA, Ekici K. Presence of Biogenic Amines in Food and Their Public Health Implications: A Review. J Food Prot . 2021;84(9):1539–1548. doi: 10.4315/JFP-21-047. [DOI] [PubMed] [Google Scholar]
  • 20.Chung BY, Park SY, Byun YS et al. Effect of Different Cooking Methods on Histamine Levels in Selected Foods. Ann Dermatol . 2017;29(6):706–714. doi: 10.5021/ad.2017.29.6.706. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.EFSA Panel on Biological Hazards (BIOHAZ) Scientific Opinion on risk based control of biogenic amine formation in fermented foods. EFSA Journal . 2011;9(10):2393. [Google Scholar]
  • 22.Ladero V, Calles-Enriquez M, Fernandez MA, Alvarez M. Toxicological Effects of Dietary Biogenic Amines. Curr Nutr Food Sci . 2010;6:145–156. [Google Scholar]
  • 23.Zaman MZ, Abdulamir AS, Bakar FA, Jinap Selamat J, Bakar J. A Review: Microbiological, Physicochemical and Health Impact of High Level of Biogenic Amines in Fish Sauce. American Journal of Applied Sciences . 2009;6:1199–1211. [Google Scholar]
  • 24.Al Bulushi I, Poole S, Deeth HC, Dykes GA. Biogenic amines in fish: roles in intoxication, spoilage, and nitrosamine formation--a review. Crit Rev Food Sci Nutr . 2009;49(4):369–77. doi: 10.1080/10408390802067514. [DOI] [PubMed] [Google Scholar]
  • 25.Shalaby AR. Significance of biogenic amines to food safety and human health. Food Research International . 1996;29:675–690. [Google Scholar]
  • 26.Suzzi G, Torriani S. Editorial: Biogenic amines in foods. Front Microbiol . 2015;6 doi: 10.3389/fmicb.2015.00472. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Mohammed GI, Bashammakh AS, Alsibaai AA, Alwael H, El-Shahawi MS. A critical overview on the chemistry, clean-up and recent advances in analysis of biogenic amines in foodstuffs. TrAC Trends in Analytical Chemistry . 2016;78:84–94. [Google Scholar]
  • 28.Scavnicar A, Rogelj I, Kocar D, Kse S, Pompe M. Determination of Biogenic Amines in Cheese by Ion Chromatography with Tandem Mass Spectrometry Detection. J AOAC Int . 2018 doi: 10.5740/jaoacint.16-0006. doi: [DOI] [PubMed] [Google Scholar]
  • 29.Bedia Erim F. Recent analytical approaches to the analysis of biogenic amines in food samples. Trends Analyt Chem . 2013;52:239–247. [Google Scholar]
  • 30.Onal A, Tekkeli SE, Onal C. A review of the liquid chromatographic methods for the determination of biogenic amines in foods. Food Chem . 2013;138(1):509–515. doi: 10.1016/j.foodchem.2012.10.056. [DOI] [PubMed] [Google Scholar]
  • 31.Palermo C, Muscarella M, Nardiello D, Iammarino M, Centonze D. A multiresidual method based on ion-exchange chromatography with conductivity detection for the determination of biogenic amines in food and beverages. Anal Bioanal Chem . 2013;405(2–3):1015–1023. doi: 10.1007/s00216-012-6439-z. [DOI] [PubMed] [Google Scholar]
  • 32.Loizzo MR, Menichini F, Picci N, Puoci F, Spizzirri UG. Technological aspects and analytical determination of biogenic amines in cheese. Trends in Food Science & Technology . 2013;30:38–55. [Google Scholar]
  • 33.Mayer HK, Fiechter G, Fischer E. A new ultra-pressure liquid chromatography method for the determination of biogenic amines in cheese. J Chromatogr A . 2010;1217:3251–3257. doi: 10.1016/j.chroma.2009.09.027. [DOI] [PubMed] [Google Scholar]
  • 34.Til HP, Falke HE, Prinsen MK, Willems MI. Acute and subacute toxicity of tyramine, spermidine, spermine, putrescine and cadaverine in rats. Food Chemistry and Toxicology . 1997;35(3–4):337–48. doi: 10.1016/s0278-6915(97)00121-x. [DOI] [PubMed] [Google Scholar]
  • 35.Hungerford JM. Scombroid poisoning: a review. Toxicon . 2010;56(2):231–243. doi: 10.1016/j.toxicon.2010.02.006. [DOI] [PubMed] [Google Scholar]
  • 36.Linares DM, del Rio B, Redruello B et al. Comparative analysis of the in vitro cytotoxicity of the dietary biogenic amines tyramine and histamine. Food Chem . 2016;197(Pt A):658–663. doi: 10.1016/j.foodchem.2015.11.013. [DOI] [PubMed] [Google Scholar]
  • 37.Sánchez-Pérez S, Comas-Basté O, Rabell-González J, Veciana-Nogués MT, Latorre-Moratalla ML, Vidal-Carou MC. Biogenic Amines in Plant-Origin Foods: Are They Frequently Underestimated in Low-Histamine Diets. Foods . 2018;7(12):205. doi: 10.3390/foods7120205. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Sivamaruthi BS, Kesika P, Chaiyasut C. A narrative review on biogenic amines in fermented fish and meat products. J Food Sci Technol . 2021;58(5):1623–1639. doi: 10.1007/s13197-020-04686-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Lapa-Guimarães J, Trattner S, Pickova J. Effect of processing on amine formation and the lipid profile of cod (Gadus morhua) roe. Food Chem . 2011;129(3):716–723. doi: 10.1016/j.foodchem.2011.05.010. [DOI] [PubMed] [Google Scholar]
  • 40.Jihao Z, Jinhong W, Huiyun C, Sui N. Review on biological degradation of biogenic amines in food. International Journal of Agricultural Science and Food Technology . 2021:331–334. [Google Scholar]
  • 41.Coton M, Delbés-Paus C, Irlinger F et al. Diversity and assessment of potential risk factors of Gram-negative isolates associated with French cheeses. Food Microbiol . 2012;29(1):88–98. doi: 10.1016/j.fm.2011.08.020. [DOI] [PubMed] [Google Scholar]
  • 42.Russo P, Spano G, Arena M et al. Are consumers aware of the risks related to Biogenic Amines in food. Curr Res Technol Educ Top Appl Microbiol Microb Biotechnol . 2010:1087–1095. [Google Scholar]
  • 43.Wójcik W, Łukasiewicz M, Puppel K. Biogenic amines: formation, action and toxicity—a review. J Sci Food Agric . 2021;101(7):2634–2640. doi: 10.1002/jsfa.10928. [DOI] [PubMed] [Google Scholar]
  • 44.Önal A. A review: Current analytical methods for the determination of biogenic amines in foods. Food Chem . 2007;103(4):1475–1486. [Google Scholar]
  • 45.Leisner JJ, Millan JC, Huss HH, Larsen LM. Production of histamine and tyramine by lactic acid bacteria isolated from vacuum-packed sugar-salted fish. J Appl Bacteriol . 1994;76(5):417–423. doi: 10.1111/j.1365-2672.1994.tb01097.x. [DOI] [PubMed] [Google Scholar]
  • 46.Gillman PK. A reassesment of the safety profile of monoamine oxidase inhibitors: elucidating tired old tyramine myths. J Neural Transm (Vienna) . 2018;125(11):1707–1717. doi: 10.1007/s00702-018-1932-y. [DOI] [PubMed] [Google Scholar]
  • 47.Ramsay R. Molecular Aspects of the Activity and Inhibition of the FAD-Containing Monoamine Oxidases. 2019:397–425. [Google Scholar]
  • 48.Stahl SM, Felker A. Monoamine Oxidase Inhibitors: A Modern Guide to an Unrequited Class of Antidepressants. CNS Spectrums . 2008;13(10):855–871. doi: 10.1017/s1092852900016965. [DOI] [PubMed] [Google Scholar]
  • 49.Dollery CT, Brown MJ, Davies DS, Lewis PJ, Strolin-Benedetti M. Oral absorption and concentration-effect relationship of tyramine with and without cimoxatone, a type-A specific inhibitor of monoamine oxidase. Clin Pharmacol Ther . 1983;34(5):651–662. doi: 10.1038/clpt.1983.228. [DOI] [PubMed] [Google Scholar]
  • 50.Van den Eynde V. The trace amine theory of spontaneous hypertension as induced by classic monoamine oxidase inhibitors. J Neural Transm (Vienna) . 2021;128(11):1741–1756. doi: 10.1007/s00702-021-02399-9. [DOI] [PubMed] [Google Scholar]
  • 51.Paulsen P, Grossgut R, Bauer F, Rauscher-Gabernig E. Estimates of maximum tolerable levels of tyramine content in foods in Austria. Journal of food and nutrition research . 2012;51:52–59. [Google Scholar]
  • 52.Lader MH, Sakalis G, Tansella M. Interactions between sympathomimetic amines and a new monoamine oxidase inhibitor. Psychopharmacologia . 1970;18(1):118–123. doi: 10.1007/BF00402391. [DOI] [PubMed] [Google Scholar]
  • 53.Bieck PR, Antonin KH. Oral tyramine pressor test and the safety of monoamine oxidase inhibitor drugs: comparison of brofaromine and tranylcypromine in healthy subjects. J Clin Psychopharmacol . 1988;8(4):237–245. [PubMed] [Google Scholar]
  • 54.Korn A, Eichler HG, Fischbach R, Gasic S. Moclobemide, a new reversible MAO inhibitor—interaction with tyramine and tricyclic antidepressants in healthy volunteers and depressive patients. Psychopharmacology (Berl) . 1986;88(2):153–157. doi: 10.1007/BF00652232. [DOI] [PubMed] [Google Scholar]
  • 55.Bar-Am O, Gross A, Friedman R, Finberg JP. Cardiovascular baroreceptor activity and selective inhibition of monoamine oxidase. Eur J Pharmacol . 2012;15(683):226–230. doi: 10.1016/j.ejphar.2012.03.026. [DOI] [PubMed] [Google Scholar]
  • 56.Morton C, Hickey-Dwyer M. Cortical blindness after nifedipine treatment. BMJ . 1992;305(6855):693. doi: 10.1136/bmj.305.6855.693-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Gillman PK. Advances pertaining to the pharmacology and interactions of irreversible nonselective monoamine oxidase inhibitors. Journal of Clinical Psychopharmacology . 2011;31(1):66–74. doi: 10.1097/JCP.0b013e31820469ea. [DOI] [PubMed] [Google Scholar]
  • 58.Van den Eynde V, Abdelmoemin WR, Abraham MM et al. The prescriber’s guide to classic MAO-inhibitors (phenelzine, tranylcypromine, isocarboxazid) for treatment-resistant depression. Forthcoming . doi: 10.1017/S1092852922000906. [DOI] [PubMed] [Google Scholar]
  • 59.Bieck PR, Antonin KH. Tyramine potentiation during treatment with MAO inhibitors: brofaromine and moclobemide vs irreversible inhibitors. J Neural Transm Suppl . 1989;28:21–31. [PubMed] [Google Scholar]
  • 60.VanDenBerg CM, Blob LF, Kemper EM, Azzaro AJ. Tyramine pharmacokinetics and reduced bioavailability with food. J Clin Pharmacol . 2003;43(6):604–609. [PubMed] [Google Scholar]
  • 61.Di Stefano AF, Rusca A. Pressor response to oral tyramine during co-administration with safinamide in healthy volunteers. Naunyn Schmiedebergs Arch Pharmacol . 2011;384(6):505–515. doi: 10.1007/s00210-011-0674-2. [DOI] [PubMed] [Google Scholar]
  • 62.Rafehi M, Faltraco F, Matthaei J et al. Highly Variable Pharmacokinetics of Tyramine in Humans and Polymorphisms in OCT1, CYP2D6, and MAO-A. Front Pharmacol . 2019;10:1297. doi: 10.3389/fphar.2019.01297. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Berlin I, Zimmer R, Cournot A, Payan C, Pedarriosse AM, Puech AJ. Determination and comparison of the pressor effect of tyramine during long-term moclobemide and tranylcypromine treatment in healthy volunteers. Clin Pharmacol Ther . 1989;46(3):344–351. doi: 10.1038/clpt.1989.149. [DOI] [PubMed] [Google Scholar]
  • 64.Van den Eynde V, Gillman PK. The larger than linear effect of high-dose tyramine on systolic blood pressure—the MAOI diet modified. Int J Psychiatry Clin Pract . 2020;24(3):328. doi: 10.1080/13651501.2020.1743863. [DOI] [PubMed] [Google Scholar]
  • 65.Blackwell B, Marley E, Price J, Taylor D. Hypertensive interactions between monoamine oxidase inhibitors and foodstuffs. Br J Psychiatry . 1967;113(497):349–365. doi: 10.1192/bjp.113.497.349. [DOI] [PubMed] [Google Scholar]
  • 66.Walker JI, Davidson J, Zung WW. Patient compliance with MAO inhibitor therapy. J Clin Psychiatry . 1984;45(7 Pt 2):78–80. [PubMed] [Google Scholar]
  • 67.Gardner DM, Shulman KI, Walker SE, Tailor SA. The making of a user friendly MAOI diet. J Clin Psychiatry . 1996;57(3):99–104. [PubMed] [Google Scholar]
  • 68.Tsakona C. Histamine poisoning and cheese. Clinical and Translational Allergy . 2015;5(3):P107. [Google Scholar]
  • 69.Shulpekova YO, Nechaev VM, Popova IR et al. Food Intolerance: The Role of Histamine. Nutrients . 2021;13(9):3207. doi: 10.3390/nu13093207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Feng C, Teuber S, Gershwin ME. Histamine (Scombroid) Fish Poisoning: a Comprehensive Review. Clin Rev Allergy Immunol . 2016;50(1):64–69. doi: 10.1007/s12016-015-8467-x. [DOI] [PubMed] [Google Scholar]
  • 71.Maintz L, Novak N. Histamine and histamine intolerance. Am J Clin Nutr . 2007;85(5):1185–1196. doi: 10.1093/ajcn/85.5.1185. [DOI] [PubMed] [Google Scholar]
  • 72.Jarisch R. Histamin-Intoleranz . 2004 Histamin und Seekrankheit 2nd ed. Thieme. [Google Scholar]
  • 73.Taylor SL, Stratton JE, Nordlee JA. Histamine Poisoning (Scombroid Fish Poisoning): An Allergy-Like Intoxication. J Toxicol Clin Toxicol . 1989;27(4–5):225–240. doi: 10.3109/15563658908994420. [DOI] [PubMed] [Google Scholar]
  • 74.Ricci G, Zannoni M, Cigolini D et al. Tryptase serum level as a possible indicator of scombroid syndrome. Clin Toxicol (Phila) . 2010;48(3):203–206. doi: 10.3109/15563651003649177. [DOI] [PubMed] [Google Scholar]
  • 75.Huang H, Li Y, Liang J, Finkelman FD. Molecular Regulation of Histamine Synthesis. Front Immunol . 2018;9 doi: 10.3389/fimmu.2018.01392. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Boudíková-Girard B, Scott MC, Weinshilboum R. Histamine N-methyltransferase: inhibition by monoamine oxidase inhibitors. Agents Actions . 1993;40(1–2):1–10. doi: 10.1007/BF01976745. [DOI] [PubMed] [Google Scholar]
  • 77.Ulrich S, Ricken R, Adli M. Tranylcypromine in mind (Part I): Review of pharmacology. Eur Neuropsychopharmacol . 2017;27(8):697–713. doi: 10.1016/j.euroneuro.2017.05.007. [DOI] [PubMed] [Google Scholar]
  • 78.Holt A, Todd KG, Baker GB. The effects of chronic administration of inhibitors of flavin and quinone amine oxidases on imidazoline I(1) receptor density in rat whole brain. Ann N Y Acad Sci . 2003;1009:309–322. doi: 10.1196/annals.1304.040. [DOI] [PubMed] [Google Scholar]
  • 79.Holt A, Berry MD, Boulton AA. On the Binding of Monoamine Oxidase Inhibitors to Some Sites Distinct from the MAO Active Site, and Effects Thereby Elicited. Neurotoxicology . 2004;25(1):251–266. doi: 10.1016/S0161-813X(03)00104-9. [DOI] [PubMed] [Google Scholar]
  • 80.Buffoni F, Banchelli G, Ignesti G, Pirisino R, Raimondi L. The role of semicarbazide-sensitive amine oxidase with a high affinity for benzylamine (Bz. SSAO) in the catabolism of histamine in the mesenteric arterial bed of the rat. Agents Actions . 1994;42(1–2):1–6. doi: 10.1007/BF02014291. [DOI] [PubMed] [Google Scholar]
  • 81.Senanayake N, Vyravanathan S. Histamine reactions due to ingestion of tuna fish (Thunnus argentivittatus) in patients on anti-tuberculosis therapy. Toxicon . 1981;19:184–185. doi: 10.1016/0041-0101(81)90132-x. [DOI] [PubMed] [Google Scholar]
  • 82.Uragoda CG, Lodha SC. Histamine intoxication in a tuberculous patient after ingestion of cheese. Tubercle . 1979;60(1):59–61. doi: 10.1016/0041-3879(79)90058-8. [DOI] [PubMed] [Google Scholar]
  • 83.Uragoda CG. Histamine poisoning in tuberculous patients after ingestion of tuna fish. Am Rev Respir Dis . 1980;121(1):157–159. doi: 10.1164/arrd.1980.121.1.157. [DOI] [PubMed] [Google Scholar]
  • 84.Aloysius DJ, Uragoda CG. Histamine poisoning on ingestion of tuna fish. J Trop Med Hyg . 1983;86(1):13–5. [PubMed] [Google Scholar]
  • 85.Diao YF. [Histamine-like reaction in tuberculosis patients eating fish containing much histamine under treatment with isoniazid in 277 cases] Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi . 1986;9(5):267–9. 317–8. [PubMed] [Google Scholar]
  • 86.Morinaga S, Kawasaki A, Hirata H, Suzuki S, Mizushima Y. Histamine poisoning after ingestion of spoiled raw tuna in a patient taking isoniazid. Intern Med . 1997;36(3):198–200. doi: 10.2169/internalmedicine.36.198. [DOI] [PubMed] [Google Scholar]
  • 87.Miki M, Ishikawa T, Okayama H. An outbreak of histamine poisoning after ingestion of the ground saury paste in eight patients taking isoniazid in tuberculous ward. Intern Med . 2005;44(11):1133–6. doi: 10.2169/internalmedicine.44.1133. [DOI] [PubMed] [Google Scholar]
  • 88.Kahana LM, Todd E. Histamine intoxication in a tuberculosis patient on isoniazid. Canadian Disease Weekly Report . 1981;7:79–80. [Google Scholar]
  • 89.Cacabelos R, Torrellas C. Medical Epigenetics . Academic Press; 2016. Chapter 32—Pharmacoepigenomics; pp. 585–617. In: Tollefsbol TO, ed. [Google Scholar]
  • 90.Benedetti MS, Ancher JF, Sontag N. Monoamine oxidase inhibitors and histamine metabolism. Experientia . 1980;36(7):818–810. doi: 10.1007/BF01978589. [DOI] [PubMed] [Google Scholar]
  • 91.Gey KF, Pletscher A, Burkard W. Effect of inhibitors of monoamine oxidase on various enzymes and on the storage of monoamines. Ann N Y Acad Sci . 1963;107:1147–1151. doi: 10.1111/j.1749-6632.1963.tb13357.x. [DOI] [PubMed] [Google Scholar]
  • 92.Neumann J, Grobe JM, Weisgut J et al. Histamine can be Formed and Degraded in the Human and Mouse Heart. Front Pharmacol . 2021;12 doi: 10.3389/fphar.2021.582916. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 93.Gillman PK. More on Mrs Murphy’s Beans: Or “Do Us a Fava”. J Clin Psychopharmacol . 2010;30(2):215–216. doi: 10.1097/JCP.0b013e3181d47f8c. [DOI] [PubMed] [Google Scholar]
  • 94.Blackwell B, Marley E. Interactions of yeast extracts and their constituents with monoamine oxidase inhibitors. Br J Pharmacol . 1965;26(1):142–161. doi: 10.1111/j.1476-5381.1966.tb01817.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 95.Gilbert C. Optimal physical performance in athletes: key roles of dopamine in a specific neurotransmitter/hormonal mechanism. Mech Ageing Dev . 1995;84(2):83–102. doi: 10.1016/0047-6374(95)01635-x. [DOI] [PubMed] [Google Scholar]
  • 96.Jaber M, Robinson SW, Missale C, Caron MG. Dopamine receptors and brain function. Neuropharmacology . 1996;35(11):1503–1519. doi: 10.1016/s0028-3908(96)00100-1. [DOI] [PubMed] [Google Scholar]
  • 97.Jose PA, Eisner GM, Felder RA. Regulation of blood pressure by dopamine receptors. Nephron Physiol . 2003;95(2):p19–27. doi: 10.1159/000073676. [DOI] [PubMed] [Google Scholar]
  • 98.Martel CL, Mckie JB, Adams JD, McComb JG, Weiss MH, Zlokovic BV. Transport of DA at the blood-brain barrier of the guinea pig: inhibition by psychotropic drugs and nicotine. Pharm Res . 1996;13(2):290–295. doi: 10.1023/a:1016007601794. [DOI] [PubMed] [Google Scholar]
  • 99.Monge-Fuentes V, Biolchi Mayer A, Lima MR et al. Dopamine-loaded nanoparticle systems circumvent the blood–brain barrier restoring motor function in mouse model for Parkinson’s Disease. Sci Rep . 2021;11(1):15185. doi: 10.1038/s41598-021-94175-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 100.Ortega E, Blanco S, Ruiz A, Peinado MÁ, Peralta S, Morales ME. Lipid nanoparticles for the transport of drugs like dopamine through the blood-brain barrier. Journal of Nanoparticle Research . 2021;23(4):106. [Google Scholar]
  • 101.Kanazawa K, Sakakibara H. High Content of Dopamine, a Strong Antioxidant, in Cavendish Banana. J Agric Food Chem . 2000;48(3):844–848. doi: 10.1021/jf9909860. [DOI] [PubMed] [Google Scholar]
  • 102.de Jong WHA, Eisenhofer G, Post WJ, Muskiet FAJ, de Vries EGE, Kema IP. Dietary Influences on Plasma and Urinary Metanephrines: Implications for Diagnosis of Catecholamine-Producing Tumors. The Journal of Clinical Endocrinology & Metabolism . 2009;94(8):2841–2849. doi: 10.1210/jc.2009-0303. [DOI] [PubMed] [Google Scholar]
  • 103.Jose PA, Eisner GM, Felder RA. Role of dopamine in the pathogenesis of hypertension. Clin Exp Pharmacol Physiol Suppl . 1999;26:S10–3. [PubMed] [Google Scholar]
  • 104.Ditscheid B, Fünfstück R, Busch M, Schubert R, Gerth J, Jahreis G. Effect of L-methionine supplementation on plasma homocysteine and other free amino acids: a placebo-controlled double-blind cross-over study. Eur J Clin Nutr . 2005;59(6):768–775. doi: 10.1038/sj.ejcn.1602138. [DOI] [PubMed] [Google Scholar]
  • 105.Vasdev S, Singal P, Gill V. The antihypertensive effect of cysteine. Int J Angiol . 2009;18(1):7–21. doi: 10.1055/s-0031-1278316. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 106.Poggiogalle E, Fontana M, Giusti AM et al. Amino Acids and Hypertension in Adults. Nutrients . 2019;11(7):1459. doi: 10.3390/nu11071459. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 107.Tuttle KR, Milton JE, Packard DP, Shuler LA, Short RA. Dietary Amino Acids and Blood Pressure: A Cohort Study of Patients With Cardiovascular Disease. Am J Kidney Dis . 2012;59(6):803–809. doi: 10.1053/j.ajkd.2011.12.026. [DOI] [PubMed] [Google Scholar]
  • 108.Pujos-Guillot E, Pickering G, Lyan B et al. Therapeutic paracetamol treatment in older persons induces dietary and metabolic modifications related to sulfur amino acids. Age (Dordr) . 2012;34(1):181–93. doi: 10.1007/s11357-011-9218-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 109.Urdaneta E, Idoate I, Larralde J. Drug-nutrient interactions: inhibition of amino acid intestinal absorption by fluoxetine. Br J Nutr . 1998;79(5):439–446. doi: 10.1079/bjn19980074. [DOI] [PubMed] [Google Scholar]
  • 110.Crevoisier C, Zerr P, Calvi-Gries F, Nilsen T. Effects of food on the pharmacokinetics of levodopa in a dual-release formulation. Eur J Pharm Biopharm . 2003;55(1):71–76. doi: 10.1016/s0939-6411(02)00124-8. [DOI] [PubMed] [Google Scholar]
  • 111.Camargo SM, Vuille-dit-Bille RN, Mariotta L et al. The molecular mechanism of intestinal levodopa absorption and its possible implications for the treatment of Parkinson’s disease. J Pharmacol Exp Ther . 2014;351(1):114–123. doi: 10.1124/jpet.114.216317. [DOI] [PubMed] [Google Scholar]
  • 112.Creese I, Iversen SD. The role of forebrain dopamine systems in amphetamine induced stereotyped behavior in the rat. Psychopharmacologia . 1974;39(4):346–357. doi: 10.1007/BF00422974. [DOI] [PubMed] [Google Scholar]
  • 113.Richard DM, Dawes MA, Mathias CW, Acheson A, Hill-Kapturczak N, Dougherty DM. L-Tryptophan: Basic Metabolic Functions, Behavioral Research and Therapeutic Indications. International Journal of Tryptophan Research . 2009;2:IJTR.S2129. doi: 10.4137/ijtr.s2129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 114.McKeith I. Donald Eccleston. BMJ . 2018;361:k2054. [Google Scholar]
  • 115.Soh NL, Walter G. Tryptophan and depression: can diet alone be the answer. Acta Neuropsychiatrica . 2011;23(1):3–11. [Google Scholar]
  • 116.Latorre-Moratalla ML, Bover-Cid S, Talon R et al. Distribution of aminogenic activity among potential autochthonous starter cultures for dry fermented sausages. J Food Prot . 2010;73(3):524–528. doi: 10.4315/0362-028x-73.3.524. [DOI] [PubMed] [Google Scholar]
  • 117.Lorenzo JM, Munekata PES, Domínguez R. Role of autochthonous starter cultures in the reduction of biogenic amines in traditional meat products. Current Opinion in Food Science . 2017;14:61–65. [Google Scholar]
  • 118.Gardini F, Ozogul Y, Suzzi G, Tabanelli G, Ozogul F. Technological Factors Affecting Biogenic Amine Content in Foods: A Review. Front Microbiol . 2016;7:1218. doi: 10.3389/fmicb.2016.01218. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 119.Kandasamy S, Yoo J, Yun J, Kang HB, Seol K-H, Ham J-S. Quantitative Analysis of Biogenic Amines in Different Cheese Varieties Obtained from the Korean Domestic and Retail Markets. Metabolites . 2021;11(1):31. doi: 10.3390/metabo11010031. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 120.Andersen G, Marcinek P, Sulzinger N, Schieberle P, Krautwurst D. Food sources and biomolecular targets of tyramine. Nutr Rev . 2019;77(2):107–115. doi: 10.1093/nutrit/nuy036. [DOI] [PubMed] [Google Scholar]
  • 121. European Community. BIAMFOOD: Controlling Biogenic Amines in Traditional Food Fermentations . 2011 http://cordiseuropaeu/project/rcn/88095_enhtml . [Google Scholar]
  • 122.Chong CY, Abu Bakar F, Russly AR, Jamilah B, Mahyudin NA. The effects of food processing on biogenic amines formation. International Food Research Journal . 2011;18:867–876. [Google Scholar]
  • 123.Bargossi E, Tabanelli G, Montanari C et al. Tyrosine decarboxylase activity of enterococci grown in media with different nutritional potential: tyramine and 2-phenylethylamine accumulation and tyrDC gene expression. Front Microbiol . 2015;6:259. doi: 10.3389/fmicb.2015.00259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 124.Marcobal A, De Las Rivas B, Landete JM, Tabera L, Muñoz R. Tyramine and Phenylethylamine Biosynthesis by Food Bacteria. Crit Rev Food Sci Nutr . 2012;525:448–467. doi: 10.1080/10408398.2010.500545. [DOI] [PubMed] [Google Scholar]
  • 125.Loomer HP, Saunders JC, Kline NS. A clinical and pharmacodynamic evaluation of iproniazid as a psychic energizer. Psychiatr Res Rep Am Psychiatr Assoc . 1957;8:129–141. [PubMed] [Google Scholar]
  • 126.Robinson E. Psychopharmacology: From serendipitous discoveries to rationale design, but what next. Brain and Neuroscience Advances . 2018;2:2398212818812629. doi: 10.1177/2398212818812629. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 127.Kosikowski KV. A quantitative appraisal of the free amino acids in foreign type cheese. J Dairy Sci . 1954;37(2):167–172. [Google Scholar]
  • 128.Bullock D, Irvine O. A chromatographic study of Cheddar cheese ripening. J Dairy Sci . 1956;39(9):1229–1235. [Google Scholar]
  • 129.Blackwell B. Hypertensive Crisis Due to Monoamine-Oxidase Inhibitors. Lancet . 1963;38:849–850. doi: 10.1016/s0140-6736(63)92743-0. [DOI] [PubMed] [Google Scholar]
  • 130.Mccormick WO, Blackwell B. Tranycypromine. Lancet . 1963;281(7273):167–168. [Google Scholar]
  • 131.Blackwell B. Toxic Effects of Monoamine-Oxidase Inhibitors. Lancet . 1964;2(7351):150–151. [PubMed] [Google Scholar]
  • 132.Blackwell B, Marley E. Interaction between Cheese and Monoamine-Oxidase Inhibitors in Rats and Cats. Lancet . 1964;1(7332):530–531. doi: 10.1016/s0140-6736(64)92914-9. [DOI] [PubMed] [Google Scholar]
  • 133.Blackwell B, Marley E, Ryle A. Hypertensive Crisis Associated with Monoamine-Oxidase Inhibitors. Lancet . 1964;1(7335):722–723. doi: 10.1016/s0140-6736(64)91553-3. [DOI] [PubMed] [Google Scholar]
  • 134.Blackwell B, Mabbitt LA. Tyramine in Cheese Related to Hypertensive Crises after Monoamine-Oxidase Inhibition. Lancet . 1965;1(7392):938–940. doi: 10.1016/s0140-6736(65)91257-2. [DOI] [PubMed] [Google Scholar]
  • 135.Blackwell B, Marley E, Mabbitt LA. Effects of Yeast Extract after Monoamine-Oxidase Inhibition. Lancet . 1965;1(7392):940–943. doi: 10.1016/s0140-6736(65)91258-4. [DOI] [PubMed] [Google Scholar]
  • 136.Blackwell B, Mabbitt L, Marley E. Histamine and tyramine content of yeast products. J Food Sci . 1969;34(1):47–51. [Google Scholar]
  • 137.Fiechter G, Sivec G, Mayer HK. Application of UHPLC for the simultaneous analysis of free amino acids and biogenic amines in ripened acid-curd cheeses. J Chromatogr B . 2013;927:191–200. doi: 10.1016/j.jchromb.2012.12.006. [DOI] [PubMed] [Google Scholar]
  • 138.Bunkova L, Bunka F, Mantlova G et al. The effect of ripening and storage conditions on the distribution of tyramine, putrescine and cadaverine in Edam-cheese. Food Microbiol . 2010;27(7):880–888. doi: 10.1016/j.fm.2010.04.014. [DOI] [PubMed] [Google Scholar]
  • 139.Spizzirri GU, Restuccia D, Curcio M, Parisi OI, Iemma F, Picci N. Determination of biogenic amines in different cheese samples by LC with evaporative light scattering detector. J Food Compost Anal . 2013;29:43–51. [Google Scholar]
  • 140.Linares DM, Del Rio B, Ladero V et al. Factors Influencing Biogenic Amines Accumulation in Dairy Products. Front Microbiol . 2012;3:180. doi: 10.3389/fmicb.2012.00180. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 141.McCabe B. Dietary tyramine and other pressor amines in MAOI regimens: a review. J Am Diet Assoc . 1986;86(8):1059–1064. [PubMed] [Google Scholar]
  • 142.McCabe-Sellers BJ, Staggs CG, Bogle ML. Tyramine in foods and monoamine oxidase inhibitor drugs: A crossroad where medicine, nutrition, pharmacy, and food industry converge. J Food Compost Anal . 2006;19:S58–S65. [Google Scholar]
  • 143.Schirone M, Tofalo R, Visciano P, Corsetti A, Suzzi G. Biogenic amines in italian pecorino cheese. Front Microbiol . 2012;3:171. doi: 10.3389/fmicb.2012.00171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 144.Mayer HK, Fiechter G. UHPLC analysis of biogenic amines in different cheese varieties. Food Control . 2018;93:9–16. [Google Scholar]
  • 145.Almena-Aliste M, Mietton B, Donnelly Catherine W. Cheese Classification, Characterization, and Categorization: A Global Perspective. Microbiology Spectrum . 2014;2(1):2.1.09. doi: 10.1128/microbiolspec.CM-0003-2012. [DOI] [PubMed] [Google Scholar]
  • 146.Novella-Rodriguez S, Veciana-Nogues MT, Vidal-Carou MC. Biogenic amines and polyamines in milks and cheeses by iron high performance liquid chromatography. J Agric Food Chem . 2000;48:5117–5123. doi: 10.1021/jf0002084. [DOI] [PubMed] [Google Scholar]
  • 147.Novella-Rodriguez S, Veciana-Nogues MT, Izquerdo-Pulido M, Vidal-Carou MC, Roig-Sagues AX, Trujillo-Mesa AJ. Distribution of biogenic amines and polyamines in cheese. J Food Sci . 2003;68:750–755. [Google Scholar]
  • 148.Bonczar G, Filipczak-Fiutak M, Pluta-Kubica A, Duda I, Walczycka M, Staruch L. The range of protein hydrolysis and biogenic amines content in selected acid-and rennet-curd cheeses. Chemical Papers . 2018;72(10):2599–2606. doi: 10.1007/s11696-018-0490-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 149.Horwitz D, Lovenberg W, Engelman K, Sjoerdsma A. Monoamine Oxidase Inhibitors, Tyramine, and Cheese. JAMA . 1964;188:1108–10. doi: 10.1001/jama.1964.03060390010002. [DOI] [PubMed] [Google Scholar]
  • 150.Asatoor AM, Levi AJ, Milne MD. Tranylcypromine and Cheese. Lancet . 1963;2(7310):733–4. doi: 10.1016/s0140-6736(63)90368-4. [DOI] [PubMed] [Google Scholar]
  • 151.Colonna P, Adda J. Dosage de la Tyramine, Tryptamine et Histamine dans Quelque Fromages Francais. Lait . 1976;56:143–153. [Google Scholar]
  • 152.De Vuyst A, Vervack W, Foulon M. Détection d’amines non volatiles dans quelques fromages. Le Lait . 1976;557:414–422. [Google Scholar]
  • 153.Voight M, Eitenmiller R. Fluorescent quantitation of biologically active amines in foods with 7 chloro 4 nitro benzo-furazan. J Food Sci . 1974;39 [Google Scholar]
  • 154.Komprda T, Dohnal V, Závodníková R. Contents of Some Biologically Active Amines in a Czech Blue-vein Cheese. Czech J Food Sci . 2008;26:428–440. [Google Scholar]
  • 155.Samkova E, Dadáková E, Pelikánová T. Changes in biogenic amine and polyamine contents in smear-ripened cheeses during storage. Eur Food Res Technol . 2013;237(3):309–314. [Google Scholar]
  • 156.Pleva P, Buňková L, Theimrová E, Bartošáková V, Buňka F, Purevdorj K. Biogenic amines in smear and mould-ripened cheeses. Potravinarstvo . 2014;8 [Google Scholar]
  • 157.Valsamaki K, Michaelidou A, Polychroniadou A. Biogenic amine production in Feta cheese. Food Chem . 2000;71(2):259–266. [Google Scholar]
  • 158.Rea MS, Franz CMAP, W.H. Holzapfel WH, Cogan TM. Development of enterococci and production of tyramine during the manufacture and ripening of Cheddar cheese. Irish Journal of Agricultural and Food Research . 2004;43:247–258. [Google Scholar]
  • 159.Tarjan V, Janossy G. The role of biogenic amines in foods. Nahrung . 1978;22:285–289. doi: 10.1002/food.19780220304. [DOI] [PubMed] [Google Scholar]
  • 160.Komprda T, Burdychova R, Dohnal V, Cwikova O, Sladkova P, Dvorackova H. Some factors influencing biogenic amines and polyamines content in Dutch-type semi-hard cheese. Eur Food Res Technol . 2008;227:29–36. [Google Scholar]
  • 161.Komprda T, Burdychova R, Dohnal V, Cwikova O, Sladkova P, Dvorackova H. Tyramine production in Dutch-type semi-hard cheese from two different producers. Food Microbiol . 2008;25(2):219–227. doi: 10.1016/j.fm.2007.11.006. [DOI] [PubMed] [Google Scholar]
  • 162.Novella-Rodriguez S, Veciana-Nogues MT, Roig-Sagues AX, Trujillo-Mesa AJ, Vidal-Carou MC. Influence of starter and nonstarter on the formation of biogenic amine in goat cheese during ripening. J Dairy Sci . 2002;85(10):2471–2478. doi: 10.3168/jds.S0022-0302(02)74329-4. [DOI] [PubMed] [Google Scholar]
  • 163.Bonetta S, Carraro E, Coisson JD, Travaglia F, Arlorio M. Detection of biogenic amine producer bacteria in a typical Italian goat cheese. J Food Prot . 2008;71(1):205–219. doi: 10.4315/0362-028x-71.1.205. [DOI] [PubMed] [Google Scholar]
  • 164.Ibrahim EM, Amer AA. Comparison of biogenic amines levels in different processed cheese varieties with regulatory specifications. World Journal of Dairy and Food Science . 2010;5:127–133. [Google Scholar]
  • 165.Kalac P. Biologically active polyamines in beef, pork and meat products: A review. Meat Science . 2006;73:1–11. doi: 10.1016/j.meatsci.2005.11.001. [DOI] [PubMed] [Google Scholar]
  • 166.Kalac P, Křížek M, Pelikánova T, Langova M, Veskrna O. Contents of polyamines in selected foods. Food Chem . 2005;90:561–564. [Google Scholar]
  • 167.Jairath G, Singh PK, Dabur RS, Rani M, Chaudhari M. Biogenic amines in meat and meat products and its public health significance: a review. J Food Sci Technol . 2015;52:6835–6846. [Google Scholar]
  • 168.Vinci G, Antonelli ML. Biogenic amines: quality index of freshness in red and white meat. Food Control . 2002;13:519–524. [Google Scholar]
  • 169.Ruiz-Capillas C, Jimenez-Colmenero F. Biogenic amines in meat and meat products. Crit Rev Food Sci Nutr . 2004;44(7–8):489–99. doi: 10.1080/10408690490489341. [DOI] [PubMed] [Google Scholar]
  • 170.Kozová M, Kalač P, Pelikánová T. Changes in the content of biologically active polyamines during beef loin storage and cooking. Meat Science . 2009;81:607–611. doi: 10.1016/j.meatsci.2008.10.018. [DOI] [PubMed] [Google Scholar]
  • 171.Galgano F, Favati F, Bonadio M, Lorusso V, Romano P. Role of biogenic amines as index of freshness in beef meat packed with different biopolymeric materials. Food Research International . 2009;42:1147–1152. [Google Scholar]
  • 172.Triki M, Herrero AM, Jiménez-Colmenero F, Ruiz-Capillas C. Quality Assessment of Fresh Meat from Several Species Based on Free Amino Acid and Biogenic Amine Contents during Chilled Storage. Foods . 2018;7(9):132. doi: 10.3390/foods7090132. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 173.Silva CMG, Beatriz M, Glória A. Bioactive amines in chicken breast and thigh after slaughter and during storage at 4±1 °C and in chicken-based meat products. Food Chem . 2002;78:241–248. [Google Scholar]
  • 174.Fraqueza MJ, Alfaia CM, Barreto AS. Biogenic amine formation in turkey meat under modified atmosphere packaging with extended shelf life: Index of freshness. Poult Sci . 2012;91(6):1465–72. doi: 10.3382/ps.2011-01577. [DOI] [PubMed] [Google Scholar]
  • 175.Arvanitoyannis IS, Stratakos AC. Application of Modified Atmosphere Packaging and Active/Smart Technologies to Red Meat and Poultry: A Review. Food and Bioprocess Technology . 2012;5:1423–1446. [Google Scholar]
  • 176.Dadakova E, Pelikánová T, Kalač P. Contents of biologically active polyamines in duck meat and giblets after slaughter and their changes during meat storage and cooking. Food Research International . 2012;48:28–33. [Google Scholar]
  • 177.Rokkaa M, Eerolaa S, Smolanderb M, Alakomib H, Ahvenainenb R. Monitoring of the quality of modified atmosphere packaged broiler chicken cuts stored in different temperature conditions: B. Biogenic amines as quality-indicating metabolites. Food Control . 2004;15:601–607. [Google Scholar]
  • 178.Kozova M, Kalač P, Pelikánová T. Contents of biologically active polyamines in chicken meat, liver, heart and skin after slaughter and their changes during meat storage and cooking. Food Chem . 2009;116:419–425. [Google Scholar]
  • 179.Baston O, Tofan I, Stroia AL, Moise D, Barna O. Refrigerated chicken meat freshness. Correlation between easily hydrolisable nitrogen, ph value and biogenic amine contents. The Annals of the University Dunarea de Jos of Galati . 2008:37–43. Fascicle VI, II. [Google Scholar]
  • 180.Moreira APS, Giombelli A, Labanca RA, Nelson DL, Glória MBA. Effect of Aging on Bioactive Amines, Microbial Flora, Physico-Chemical Characteristics, and Tenderness of Broiler Breast Meat. Poult Sci . 2008;87:1868–1873. doi: 10.3382/ps.2007-00370. [DOI] [PubMed] [Google Scholar]
  • 181.Kalac P. Advances in Food Science and Technology . New York: Nova Sci Publ; 2010. The roles of dietary polyamines in human health and their occurrence in foods. In A K Haghi (Ed) pp 91–112. [Google Scholar]
  • 182.Ordóñez JL, Callejón R. Chapter 5 Biogenic Amines in Non-fermented Food. Biogenic Amines in Food: Analysis, Occurrence and Toxicity . 2020:76–102. The Royal Society of Chemistry. [Google Scholar]
  • 183.Nadon CA, Ismond MA, Holley R. Biogenic amines in vacuum-packaged and carbon dioxide-controlled atmosphere-packaged fresh pork stored at -1.50 degrees C. J Food Prot . 2001;64(2):220–227. doi: 10.4315/0362-028x-64.2.220. [DOI] [PubMed] [Google Scholar]
  • 184.Ruiz-Capillas C, Jimenez-Colmenero F. The effect of an argon-containing packaging atmosphere on the quality of fresh pork sausages kept at 1 °C. Food Control . 2010;21:1331–1337. [Google Scholar]
  • 185.Curiel JA, Ruiz-Capillas C, de Las Rivas B, Carrascosa AV, Jimenez-Colmenero F, Munoz R. Production of biogenic amines by lactic acid bacteria and enterobacteria isolated from fresh pork sausages packaged in different atmospheres and kept under refrigeration. Meat Sci . 2011;88(3):368–373. doi: 10.1016/j.meatsci.2011.01.011. [DOI] [PubMed] [Google Scholar]
  • 186.Durlu-Ozkaya F, Ayhan K, Vural N. Biogenic amines produced by Enterobacteriaceae isolated from meat products. Meat Sci . 2001;58(2):163–166. doi: 10.1016/s0309-1740(00)00144-3. [DOI] [PubMed] [Google Scholar]
  • 187.Pohl R, Balon R, Berchou R. Reaction to chicken nuggets in a patient taking an MAOI. Am J Psychiatry . 1988;145(5):651. doi: 10.1176/ajp.145.5.651a. [DOI] [PubMed] [Google Scholar]
  • 188.Krausová P, Kalač P, Křížek M, Pelikánová T. Changes in the content of biologically active polyamines during storage and cooking of pig liver. Meat Science . 2007;77:269–274. doi: 10.1016/j.meatsci.2007.03.011. [DOI] [PubMed] [Google Scholar]
  • 189.Valero BV, Bauer F, Smulders FJM, Ariño A, Hagen U, Paulsen P. Biogenic Amines and Polyamines and Total Aerobic Count During Storage of Vacuum-Packaged Porcine Kidney, Liver and Spleen. Food Science and Technology International . 2005;11:337–344. [Google Scholar]
  • 190.Kozová M, Kalač P, Pelikánová T. Biologically active polyamines in pig kidneys and spleen: Content after slaughter and changes during cold storage and cooking. Meat Science . 2008;79:326–331. doi: 10.1016/j.meatsci.2007.10.013. [DOI] [PubMed] [Google Scholar]
  • 191.Hedberg DL, Gordon MW, Blueck BC. Six cases of hypertensive crisis in patients on tranylcypromine after eating chicken livers. Am J Psychiatry . 1966;122:933–937. doi: 10.1176/ajp.122.8.933. [DOI] [PubMed] [Google Scholar]
  • 192.Boulton AA, Cookson B, Paulton R. Hypertensive crisis in a patient on MAOI antidepressants following a meal of beef liver. Can Med Assoc J . 1970;102(13):1394–1395. [PMC free article] [PubMed] [Google Scholar]
  • 193.Krausová P, Kalač P, Křížek M, Pelikánová T. Content of biologically active polyamines in livers of cattle, pigs and chickens after animal slaughter. Meat Science . 2006;73:640–644. doi: 10.1016/j.meatsci.2006.03.005. [DOI] [PubMed] [Google Scholar]
  • 194.Delgado-Pando G, Cofrades S, Ruiz-Capillas C, Triki M, Jimenez-Colmenero F. Enriched n-3 PUFA/konjac gel low-fat pork liver pate: lipid oxidation, microbiological properties and biogenic amine formation during chilling storage. Meat Sci . 2012;92(4):762–767. doi: 10.1016/j.meatsci.2012.06.035. [DOI] [PubMed] [Google Scholar]
  • 195.Ruiz-Capillas C, Jimenez-Colmenero F. Biogenic amine content in Spanish retail market meat products treated with protective atmosphere and high pressure. Eur Food Res Technol . 2004;218:237–241. [Google Scholar]
  • 196.Lorenzo JM, Martínez S, Francoa I, Carballo J. Biogenic amine content during the manufacture of dry-cured lacón, a Spanish traditional meat product: Effect of some additives. Meat Science . 2007;77:287–293. doi: 10.1016/j.meatsci.2007.03.020. [DOI] [PubMed] [Google Scholar]
  • 197.Aykaç Ç, Bozkurt H, Ercan S. Significance of Biogenic Amines in Foods and Their Reduction Methods. Journal of Food Science and Engineering . 2013;3:395–410. [Google Scholar]
  • 198.Roselino MN, Maciel LF, Sirocchi V et al. Analysis of biogenic amines in probiotic and commercial salamis. J Food Compost Anal . 2020;94:103649. [Google Scholar]
  • 199.Barbieri F, Tabanelli G, Montanari C et al. Mediterranean Spontaneously Fermented Sausages: Spotlight on Microbiological and Quality Features to Exploit Their Bacterial Biodiversity. Foods . 2021;10(11):2691. doi: 10.3390/foods10112691. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 200.Leggio A, Belsito EL, De Marco R et al. Dry fermented sausages of Southern Italy: a comparison of free amino acids and biogenic amines between industrial and homemade products. J Food Sci . 2012;77(4):S170–5. doi: 10.1111/j.1750-3841.2012.02650.x. [DOI] [PubMed] [Google Scholar]
  • 201.Latorre-Moratalla ML, Bover-Cid S, Veciana-Nogues MT, Vidal-Carou MC. Control of biogenic amines in fermented sausages: role of starter cultures. Front Microbiol . 2012;3:169. doi: 10.3389/fmicb.2012.00169. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 202.Latorre-Moratalla ML, Veciana-Nogues T, Bover-Cid S et al. Biogenic amines in traditional fermented sausages produced in selected European countries. Food Chem . 2008;107:912–921. [Google Scholar]
  • 203.Gardini F, Bover-Cid S, Tofalo R et al. Modeling the aminogenic potential of Enterococcus faecalis EF37 in dry fermented sausages through chemical and molecular approaches. Appl Environ Microbiol . 2008;74(9):2740–2750. doi: 10.1128/AEM.02267-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 204.Bover-Cid S, Torriani S, Gatto V et al. Relationships between microbial population dynamics and putrescine and cadaverine accumulation during dry fermented sausage ripening. J Appl Microbiol . 2009;106(4):1397–1407. doi: 10.1111/j.1365-2672.2008.04108.x. [DOI] [PubMed] [Google Scholar]
  • 205.Hernández-Macias S, Martín-Garcia A, Ferrer-Bustins N et al. Inhibition of Biogenic Amines Formation in Fermented Foods by the Addition of Cava Lees. Front Microbiol . 2022;12 doi: 10.3389/fmicb.2021.818565. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 206.Suzzi G, Gardini F. Biogenic amines in dry fermented sausages: a review. Int J Food Microbiol . 2003;88(1):41–54. doi: 10.1016/s0168-1605(03)00080-1. [DOI] [PubMed] [Google Scholar]
  • 207.Bover-Cid S, Hugas M, Izquierdo-Pulido M, Vidal-Carou MC. Amino acid-decarboxylase activity of bacteria isolated from fermented pork sausages. Int J Food Microbiol . 2001;66(3):185–189. doi: 10.1016/s0168-1605(00)00526-2. [DOI] [PubMed] [Google Scholar]
  • 208.Komprda T, Neznalova J, Standara S, Bover-Cid S. Effect of starter culture and storage temperature on the content of biogenic amines in dry fermented sausages poličan. Meat Science . 2001;59:267–276. doi: 10.1016/s0309-1740(01)00079-1. [DOI] [PubMed] [Google Scholar]
  • 209.Papavergou EJ, Savvaidis IN, Ambrosiadis IA. Levels of biogenic amines in retail market fermented meat products. Food Chem . 2012;135(4):2750–2755. doi: 10.1016/j.foodchem.2012.07.049. [DOI] [PubMed] [Google Scholar]
  • 210.Ferreira IM, Pinho O. Biogenic amines in Portuguese traditional foods and wines. J Food Prot . 2006;69(9):2293–303. doi: 10.4315/0362-028x-69.9.2293. [DOI] [PubMed] [Google Scholar]
  • 211.Miguelez-Arrizadoa MJ, Bover-Cid S, Latorre-Moratalla ML, Vidal-Carou MC. Biogenic amines in Spanish fermented sausages as a function of diameter and artisanal or industrial origin. J Sci Food Agric . 2006;86:549–557. [Google Scholar]
  • 212.Özogul F, Özogula Y. Biogenic amine content and biogenic amine quality indices of sardines (Sardina pilchardus) stored in modified atmosphere packaging and vacuum packaging. Food Chem . 2006;99:574–578. [Google Scholar]
  • 213.Zeng X, Xia W, Yang F, Jiang Q. Changes of biogenic amines in Chinese low-salt fermented fish pieces (Suan yu) inoculated with mixed starter cultures. Int J Food Sci Technol . 2013;48(4):685–692. [Google Scholar]
  • 214.Gingerich TM, Lorca T, Flick GJ, Pierson MD, McNair HM. Biogenic amine survey and organoleptic changes in fresh, stored, and temperature-abused bluefish (Pomatomus saltatrix) J Food Prot . 1999;62(9):1033–1037. doi: 10.4315/0362-028x-62.9.1033. [DOI] [PubMed] [Google Scholar]
  • 215.Prester L. Biogenic amines in fish, fish products and shellfish: a review. Food Addit Contam Part A Chem Anal Control Expo Risk Assess . 2011;28(11):1547–1560. doi: 10.1080/19440049.2011.600728. [DOI] [PubMed] [Google Scholar]
  • 216.Özogul F, Özogula Y. Changes in Biogenic Amines in Herring Stored under Modified Atmosphere and Vacuum Pack. J Food Sci . 2002;67:2497–2501. [Google Scholar]
  • 217.Visciano P, Schirone M, Tofalo R, Suzzi G. Biogenic amines in raw and processed seafood. Front Microbiol . 2012;3:188. doi: 10.3389/fmicb.2012.00188. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 218.Emborg J, Laursen BG, Rathjen T, Dalgaard P. Microbial spoilage and formation of biogenic amines in fresh and thawed modified atmosphere-packed salmon (Salmo salar) at 2 degrees C. J Appl Microbiol . 2002;92(4):790–799. doi: 10.1046/j.1365-2672.2002.01588.x. [DOI] [PubMed] [Google Scholar]
  • 219.Ruiz-Capillas C, Moral A. Formation of biogenic amines in bulk-stored chilled hake (Merluccius merluccius L.) packed under atmospheres. J Food Prot . 2001;64(7):1045–1050. doi: 10.4315/0362-028x-64.7.1045. [DOI] [PubMed] [Google Scholar]
  • 220.Katikou P, Georgantelis D, Paleologos EK, Ambrosiadis I, Kontominas MG. Relation of Biogenic Amines’ Formation with Microbiological and Sensory Attributes in Lactobacillus-Inoculated Vacuum-Packed Rainbow Trout (Oncorhynchus mykiss) Fillets. J Agric Food Chem . 2006;54:4277–4283. doi: 10.1021/jf0602121. [DOI] [PubMed] [Google Scholar]
  • 221.Chytiri S, Paleologos E, Savvaidis I, Kontominas MG. Relation of biogenic amines with microbial and sensory changes of whole and filleted freshwater rainbow trout (Onchorynchus mykiss) stored on ice. J Food Prot . 2004;67(5):960–965. doi: 10.4315/0362-028x-67.5.960. [DOI] [PubMed] [Google Scholar]
  • 222.Emborg J, Dalgaard P. Modelling the effect of temperature, carbon dioxide, water activity and pH on growth and histamine formation by Morganella psychrotolerans. Int J Food Microbiol . 2008;128(2):226–233. doi: 10.1016/j.ijfoodmicro.2008.08.016. [DOI] [PubMed] [Google Scholar]
  • 223.Kulawik P, Dordevic D, Gambuś F, Szczurowska K, Zając M. Heavy metal contamination, microbiological spoilage and biogenic amine content in sushi available on the Polish market. J Sci Food Agric . 2018;98(7):2809–2815. doi: 10.1002/jsfa.8778. [DOI] [PubMed] [Google Scholar]
  • 224.Abajay JA, Magbojos RV, Rigor LKV, Lazaro JB, Yumang AN. Detection of histamine levels in Scombridae and Scomberesocidae using principal component analysis. AIP Conference Proceedings . 2018;2045(1):020053. [Google Scholar]
  • 225.Biji KB, Ravishankar CN, Venkateswarlu R, Mohan CO, Gopal TKS. Biogenic amines in seafood: a review. J Food Sci Technol . 2016;53(5):2210–2218. doi: 10.1007/s13197-016-2224-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 226.Debeer J, Bell J, Nolte F, Arcieri J, Correa G. Histamine Limits by Country: A Survey and Review. J Food Prot . 2021;84 doi: 10.4315/JFP-21-129. [DOI] [PubMed] [Google Scholar]
  • 227.Visciano P, Schirone M, Paparella A. An Overview of Histamine and Other Biogenic Amines in Fish and Fish Products. Foods . 2020;9(12):1795. doi: 10.3390/foods9121795. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 228.Hussein M, Foda H, Eissa K. Quality Parameters of Some Marketed Frozen Fish in Dakahlia Governorate, Egypt. Zagazig Vet J . 2022;50(1):87–96. [Google Scholar]
  • 229.Commission Regulation on microbiological criteria for foodstuffs, No 2073/2005, European Commission (15 November 2005) [Google Scholar]
  • 230.Arason S, Nguyen M, Thorarinsdottir K. Preservation of fish by curing. Seafood Processing: Technology, Quality and Safety . 2014:129–160. [Google Scholar]
  • 231.Martínez-Álvarez O, López-Caballero ME, Gómez-Guillén MC, Montero P. Fermented Foods in Health and Disease Prevention . Academic Press; 2017. Chapter 9 - Fermented Seafood Products and Health; pp. 177–202. In: Frias J, Martinez-Villaluenga C, Peñas E, eds. [Google Scholar]
  • 232.Brillet AA, Pilet M-F, Prevost H, Cardinal M, Leroi F. Effect of inoculation of Carnobacterium divergens V41, a biopreservative strain against Listeria monocytogenes risk, on the microbiological, chemical and sensory quality of cold-smoked salmon. Int J Food Microbiol . 2005;104:309–324. doi: 10.1016/j.ijfoodmicro.2005.03.012. [DOI] [PubMed] [Google Scholar]
  • 233.Jørgensen LV, Dalgaard P, Huss HH. Multiple Compound Quality Index for Cold-Smoked Salmon (Salmo salar) Developed by Multivariate Regression of Biogenic Amines and pH. J Agric Food Chem . 2000;48:2448–2453. doi: 10.1021/jf9909407. [DOI] [PubMed] [Google Scholar]
  • 234.Köse S, Koral S, Tufan B, Pompe M, Scavniçar A, Koçar D. Biogenic amine contents of commercially processed traditional fish products originating from European countries and Turkey. Eur Food Res Technol . 2012;235(4):669–683. [Google Scholar]
  • 235.Wiernasz N, Leroi F, Chevalier F et al. Salmon Gravlax Biopreservation With Lactic Acid Bacteria: A Polyphasic Approach to Assessing the Impact on Organoleptic Properties, Microbial Ecosystem and Volatilome Composition. Front Microbiol . 2020;10 doi: 10.3389/fmicb.2019.03103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 236.Periago MJ, Rodrigo J, Ros G, Rodriguez-Jerez JJ, Hernandez-Herrero M. Monitoring volatile and nonvolatile amines in dried and salted roes of tuna (Thunnus thynnus L.) during manufacture and storage. J Food Prot . 2003;66(2):335–340. doi: 10.4315/0362-028x-66.2.335. [DOI] [PubMed] [Google Scholar]
  • 237.Veciana-Nogues MT, Marine-Font A, Vidal-Carou MC. Biogenic Amines in Fresh and Canned Tuna. Effects of Canning on Biogenic Amine Contents. J Agric Food Chem . 1997;45:4324–4328. [Google Scholar]
  • 238.Veciana-Nogues MT, Vidal-Carou MC, Marine-Font A. Histamine and Tyramine in Preserved and Semi-preserved Fish Products. J Food Sci . 2006;54:1653–1655. [Google Scholar]
  • 239.Erkan N, Helle N, Ozden O. [The content of biogenic amines in canned fish from the Turkish market] Berl Munch Tierarztl Wochenschr . 2001;114(7–8):241–245. [PubMed] [Google Scholar]
  • 240.Tsai Y-H, Kunga H-F. Determination of histamine in canned mackerel implicated in a food borne poisoning. Food Control . 2005;16:579–585. [Google Scholar]
  • 241.Tsafrakidou P, Michaelidou A-M, Biliaderis CG. Fermented Cereal-based Products: Nutritional Aspects, Possible Impact on Gut Microbiota and Health Implications. Foods . 2020;9(6):734. doi: 10.3390/foods9060734. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 242.Ozdestan O, Alpözen E, Güven G. Monitoring of biogenic amines in Kumru: a traditional fermented cereal food. International Journal of Food Properties . 2012;15:972–981. [Google Scholar]
  • 243.Yeğin S, Üren A. Biogenic amine content of boza: A traditional cereal-based, fermented Turkish beverage. Food Chem . 2008;111(4):983–987. [Google Scholar]
  • 244.Ozdestan O, Uren A. Biogenic Amine Content of Tarhana: A Traditional Fermented Food. International Journal of Food Properties . 2011;16:416–428. [Google Scholar]
  • 245.Rizzello CG, Nionelli L, Coda R, De Angelis M, Gobbetti M. Effect of sourdough fermentation on stabilisation, and chemical and nutritional characteristics of wheat germ. Food Chem . 2010;119:1079–1089. [Google Scholar]
  • 246.Mannino G, Cirlincione F, Gaglio R et al. Preliminary Investigation of Biogenic Amines in Type I Sourdoughs Produced at Home and Bakery Level. Toxins (Basel) . 2022;14(5):293. doi: 10.3390/toxins14050293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 247.Populin T, Moret S, Truant S, Lanfranco S, Conte LS. A survey on the presence of free glutamic acid in foodstuffs, with and without added monosodium glutamate. Food Chem . 2007;104:1712–1717. [Google Scholar]
  • 248.Shulman KI, Walker SE, MacKenzie S, Knowles S. Dietary restriction, tyramine, and the use of monoamine oxidase inhibitors. J Clin Psychopharmacol . 1989;9(6):397–402. [PubMed] [Google Scholar]
  • 249.Guidi LR, Beatriz M, Gloria A. Bioactive amines in soy sauce: Validation of method, occurrence and potential health effects. Food Chem . 2012;133:323–328. doi: 10.1016/j.foodchem.2012.01.033. [DOI] [PubMed] [Google Scholar]
  • 250.Cho TY, Han GH, Bahn KN et al. Evaluation of biogenic amines in Korean commercial fermented foods. Korean Journal of Food Science and Technology . 2006;38:730–737. [Google Scholar]
  • 251.Mesmer RE. Don’t mix miso with MAOIs. JAMA . 1987;258(24):3515. [PubMed] [Google Scholar]
  • 252.Ma X, Bi J, Li X, Zhang G, Hao H, Hou H. Contribution of Microorganisms to Biogenic Amine Accumulation during Fish Sauce Fermentation and Screening of Novel Starters. Foods . 2021;10(11):2572. doi: 10.3390/foods10112572. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 253.Yongmeia L, Xiaohonga C, Meia J et al. Biogenic amines in Chinese soy sauce. Food Control . 2009;20:593–597. [Google Scholar]
  • 254.Stute RK, Petridis H, Steinhart A, Biernoth G. Biogenic amines in fish and soy sauce. Eur Food Res Technol . 2002;215:101–107. [Google Scholar]
  • 255.Ibe A, Tabata S, Sadamasu Y et al. [Production of tyramine in “moromi” mash during soy sauce fermentation] Shokuhin Eiseigaku Zasshi . 2003;44(5):220–226. doi: 10.3358/shokueishi.44.220. [DOI] [PubMed] [Google Scholar]
  • 256.Byun BY, Mah JH. Occurrence of biogenic amines in Miso, Japanese traditional fermented soybean paste. J Food Sci . 2012;77(12):T216–23. doi: 10.1111/j.1750-3841.2012.02983.x. [DOI] [PubMed] [Google Scholar]
  • 257.Kung H-S, Tsaia Y, Weib CI. Histamine and other biogenic amines and histamine-forming bacteria in miso products. Food Chem . 2007;101:351–356. [Google Scholar]
  • 258.Saaid MB, Saad NH, Hashim ASM, Saleh MI. Determination of biogenic amines in selected Malaysian food. Food Chem . 2009;113:1356–1362. [Google Scholar]
  • 259.Naila A, Flint S, Fletcher GC, Bremer PJ, Meerdink G. Biogenic amines and potential histamine-forming bacteria in Rihaakuru (a cooked fish paste) Food Chem . 2011;128(2):479–484. doi: 10.1016/j.foodchem.2011.03.057. [DOI] [PubMed] [Google Scholar]
  • 260.Shurtleff W, Aoyagi A. History of Worcestershire Sauce (1837–2012) . 2012 Soyinfo Center. [Google Scholar]
  • 261.Shulman KI, Walker SE. Refining the MAOI diet: tyramine content of pizzas and soy products. J Clin Psychiatry . 1999;60(3):191–193. [PubMed] [Google Scholar]
  • 262.McCabe BJ. Handbook of Food-Drug Interactions . CRC Press, Boca Raton, FL; 2003. Dietary counseling to prevent food-drug interactions; pp. 295–324. [Google Scholar]
  • 263.Moret S, Smela D, Populin T, Conte LS. A survey on free biogenic amine content of fresh and preserved vegetables. Food Chem . 2005;89(3):355–361. [Google Scholar]
  • 264.Glória MBA. Handbook of Food Science, Technology and Engineering . 1–32 Vol. 13. CRC Press, Taylor & Francis Group; 2005. 13: Bioactive amines. In: Hui Y, ed. [Google Scholar]
  • 265.Lavizzari T, Teresa Veciana-Nogues M, Bover-Cid S, Marine-Font A, Carmen Vidal-Carou M. Improved method for the determination of biogenic amines and polyamines in vegetable products by ion-pair high-performance liquid chromatography. J Chromatogr A . 2006;1129(1):67–72. doi: 10.1016/j.chroma.2006.06.090. [DOI] [PubMed] [Google Scholar]
  • 266.Kalac P, Švecovà S, Pelikaínova T. Levels of biogenic amines in typical vegetable products. Food Chem . 2002;77:349–351. [Google Scholar]
  • 267.Lavizzari T, Veciana-Nogues MT, Weingart O, Bover-Cid S, Marine-Font A, Carmen Vidal-Carou M. Occurrence of Biogenic Amines and Polyamines in Spinach and Changes during Storage under Refrigeration. J Agric Food Chem . 2007;55:9514–9519. doi: 10.1021/jf071307l. [DOI] [PubMed] [Google Scholar]
  • 268.Ly D, Kang K, Choi J-Y, Ishihara A, Back K, Lee S-G. HPLC Analysis of Serotonin, Tryptamine, Tyramine, and the Hydroxycinnamic Acid Amides of Serotonin and Tyramine in Food Vegetables. J Med Food . 2008;11(2):385–389. doi: 10.1089/jmf.2007.514. [DOI] [PubMed] [Google Scholar]
  • 269.Calixto JB, Kassuya CA, Andre E, Ferreira J. Contribution of natural products to the discovery of the transient receptor potential (TRP) channels family and their functions. Pharmacol Ther . 2005;106(2):179–208. doi: 10.1016/j.pharmthera.2004.11.008. [DOI] [PubMed] [Google Scholar]
  • 270.Cayeux I, Starkenmann C. Sensory characterization of compounds with a trigeminal effect for taste modulation purposes. Flavour: From Food to Perception . 2016:192–207. [Google Scholar]
  • 271.Mohseni Mehran SM, Golshani B. Simultaneous determination of levodopa and carbidopa from fava bean, green peas and green beans by high performance liquid gas chromatography. J Clin Diagn Res . 2013;7(6):1004–1007. doi: 10.7860/JCDR/2013/5415.3072. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 272.Goyoaga C, Burbano C, Cuadrado C et al. Content and distribution of vicine, convicine and L-DOPA during germination and seedling growth of two Vicia faba L. varieties. Eur Food Res Technol . 2008;227:1537–1542. [Google Scholar]
  • 273.Ladha SS, Walker R, Shill HA. Case of neuroleptic malignant-like syndrome precipitated by abrupt fava bean discontinuance. Mov Disord . 2005;20(5):630–1. doi: 10.1002/mds.20380. [DOI] [PubMed] [Google Scholar]
  • 274.Katzenschlager R, Evans A, Manson A et al. Mucuna pruriens in Parkinson’s disease: a double blind clinical and pharmacological study. J Neurol Neurosurg Psychiatry . 2004;75(12):1672–1677. doi: 10.1136/jnnp.2003.028761. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 275.Misra L, Wagner H. Extraction of bioactive principles from Mucuna pruriens seeds. Indian J Biochem Biophys . 2007;44(1):56–60. [PubMed] [Google Scholar]
  • 276.Tharakan B, Dhanasekaran M, Mize-Berge J, Manyam BV. Anti-Parkinson botanical Mucuna pruriens prevents levodopa induced plasmid and genomic DNA damage. Phytother Res . 2007;21(12):1124–1126. doi: 10.1002/ptr.2219. [DOI] [PubMed] [Google Scholar]
  • 277.Randhir R, Shetty K. Microwave-induced stimulation of L-DOPA, phenolics and antioxidant activity in fava bean (Vicia faba) for Parkinson’s diet. Process Biochemistry . 2003;39:1775–1784. [Google Scholar]
  • 278.Briguglio M, Dell’Osso B, Panzica G et al. Dietary Neurotransmitters: A Narrative Review on Current Knowledge. Nutrients . 2018;10:591. doi: 10.3390/nu10050591. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 279.Topal N, Bozoğlu H. Determination of L-dopa (L-3, 4-dihydroxyphenylalanine) content of some faba bean (Vicia faba L.) genotypes. Tarim Bilimleri Dergisi-journal of Agricultural Sciences . 2016;22:145–151. [Google Scholar]
  • 280.Brown C, Taniguchi G, Yip K. The monoamine oxidase inhibitor-tyramine interaction. J Clin Pharmacol . 1989;29(6):529–532. doi: 10.1002/j.1552-4604.1989.tb03376.x. [DOI] [PubMed] [Google Scholar]
  • 281.Toro-Funes N, Bosch-Fuste J, Latorre-Moratalla ML, Veciana-Nogues MT, Vidal-Carou MC. Biologically active amines in fermented and non-fermented commercial soybean products from the Spanish market. Food Chem . 2015;173:1119–1124. doi: 10.1016/j.foodchem.2014.10.118. [DOI] [PubMed] [Google Scholar]
  • 282.Shukla S, Kim J-K, Kim M. Occurrence of biogenic amines in soybean food products. Soybean and health . 2011;9:181–206. [Google Scholar]
  • 283.Yue C, Ng Q, Lim A, Lam M, Chee K. Biogenic amine content in various types of tofu: occurrence, validation and quantification. International Food Research Journal . 2019;26(3) [Google Scholar]
  • 284.Tsai CH, Chang SC, Kung H-S. Histamine contents and histamine-forming bacteria in natto products in Taiwan. Food Control . 2007;18:1026–1030. [Google Scholar]
  • 285.Kim B, Byun BY, Mah JH. Biogenic amine formation and bacterial contribution in Natto products. Food Chem . 2012;135(3):2005–2011. doi: 10.1016/j.foodchem.2012.06.091. [DOI] [PubMed] [Google Scholar]
  • 286.Hana B-Z, Romboutsb FM, Nout MJR. Amino acid profiles of sufu, a Chinese fermented soybean food. J Food Compost Anal . 2004;17:689–698. [Google Scholar]
  • 287.Gu J, Liu T, Sadiq FA et al. Biogenic amines content and assessment of bacterial and fungal diversity in stinky tofu – A traditional fermented soy curd. LWT . 2018;88:26–34. [Google Scholar]
  • 288.Guan R-F, Liu Z-F, Zhang J-J et al. Investigation of biogenic amines in sufu (furu): A Chinese traditional fermented soybean food product. Food Control . 2013;31(2):345–352. [Google Scholar]
  • 289.Kung H-S, Yiing-Horng Leeb Y-H, Changa S-C, Weic C-I, Tsaia Y-H. Histamine contents and histamine-forming bacteria in sufu products in Taiwan. Food Control . 2007;18:381–386. [Google Scholar]
  • 290.Shukla S, Park HK, Kim JK, Kim M. Determination of biogenic amines in Korean traditional fermented soybean paste (Doenjang) Food Chem Toxicol . 2010;48(5):1191–1195. doi: 10.1016/j.fct.2010.01.034. [DOI] [PubMed] [Google Scholar]
  • 291.Li KJ, Brouwer-Brolsma EM, Burton-Pimentel KJ, Vergères G, Feskens EJM. A systematic review to identify biomarkers of intake for fermented food products. Genes Nutr . 2021;16(1):5. doi: 10.1186/s12263-021-00686-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 292.Świder O, Roszko MŁ, Wójcicki M, Szymczyk K. Biogenic Amines and Free Amino Acids in Traditional Fermented Vegetables—Dietary Risk Evaluation. J Agric Food Chem . 2020;68(3):856–868. doi: 10.1021/acs.jafc.9b05625. [DOI] [PubMed] [Google Scholar]
  • 293.Kalac P, Glória MBA. Biogenic amines in cheeses, wines, beers and sauerkraut. Biological Aspects of Biogenic Amines, Polyamines and Conjugates . 2009:267–309. In: Dandrifosse G, ed. Transworld Research Network. chap 10. [Google Scholar]
  • 294.Jin YH, Lee JH, Park YK, Lee J-H, Mah J-H. The Occurrence of Biogenic Amines and Determination of Biogenic Amine-Producing Lactic Acid Bacteria in Kkakdugi and Chonggak Kimchi. Foods . 2019;8(2):73. doi: 10.3390/foods8020073. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 295.Kirschbaum J, Meier A, Brückner H. Determination of biogenic amines in fermented beverages and vinegars by pre-column derivatization with para-nitrobenzyloxycarbonyl chloride (PNZ-Cl) and reversed-phase LC. Chromatographia . 1999:117–124. 49. [Google Scholar]
  • 296.Garcia-Garcia P, Brenes-Balbuena M, Romero-Barranco C, Garrido-Fernandez A. Biogenic amines in packed table olives and pickles. J Food Prot . 2001;64(3):374–378. doi: 10.4315/0362-028x-64.3.374. [DOI] [PubMed] [Google Scholar]
  • 297.Generali JA, Hogan LC, McFarlane M, Schwab S, Hartman CR. Hypertensive crisis resulting from avocados and a MAO inhibitor. Ann Pharmacother . 1981;15(11):904–906. doi: 10.1177/106002808101501110. [DOI] [PubMed] [Google Scholar]
  • 298.Borges CV, Belin MAF, Amorim EP et al. Bioactive amines changes during the ripening and thermal processes of bananas and plantains. Food Chem . 2019:125020. doi: 10.1016/j.foodchem.2019.125020. [DOI] [PubMed] [Google Scholar]
  • 299.Waalkes TP, Sjoerdsma A, Greveling CR, Weissbach H, Udenfriend S. Serotonin, norpinephrine, and related compounds in bananas. Science . 1958;127:648–650. doi: 10.1126/science.127.3299.648. [DOI] [PubMed] [Google Scholar]
  • 300.Tazoe M, Narita M, Sakuta R, Nagai T, Narita N. Hyperkalemia and hyperdopaminemia induced by an obsessive eating of banana in an anorexia nervosa adolescent. Brain Dev . 2007;29(6):369–372. doi: 10.1016/j.braindev.2006.11.002. [DOI] [PubMed] [Google Scholar]
  • 301.Quansah L. Molecular Basis of Catecholamine Biosynthesis in Banana Fruit. MSc Thesis Hebrew University of Jerusalem . 2009 [Google Scholar]
  • 302.Guo L, Zhang Y, Li Q. Spectrophotometric determination of dopamine hydrochloride in pharmaceutical, banana, urine and serum samples by potassium ferricyanide-Fe(III) Anal Sci . 2009;25(12):1451–1455. doi: 10.2116/analsci.25.1451. [DOI] [PubMed] [Google Scholar]
  • 303.Bapat VA, Suprasanna P, Ganapathi TR, Rao PS. In Vitro Production Of L-dopa In Tissue Cultures Of Banana. Pharm Biol . 2000;38:271–273. doi: 10.1076/1388-0209(200009)3841-AFT271. [DOI] [PubMed] [Google Scholar]
  • 304.Romphophak T, Ririphanich J, Ueda Y, Abe K, Chachin K. Changes in concentrations of phenolic compounds and polyphenol oxidase activity in banana peel during storage. Food Preservation Science . 2005;31:111–115. [Google Scholar]
  • 305.Riggin RM, McCarthy MJ, Kissinger PT. Identification of salsolinol as a major dopamine metabolite in the banana. J Agric Food Chem . 1976;24(1):189–191. doi: 10.1021/jf60203a027. [DOI] [PubMed] [Google Scholar]
  • 306.Li J, Zhao F, Liu H, Li R, Wang Y, Liao X. Fermented minced pepper by high pressure processing, high pressure processing with mild temperature and thermal pasteurization. Innov Food Sci Emerg Technol . 2016;36:34–41. [Google Scholar]
  • 307.Tofalo R, Schirone M, Perpetuini G, Angelozzi G, Suzzi G, Corsetti A. Microbiological and chemical profiles of naturally fermented table olives and brines from different Italian cultivars. Antonie Van Leeuwenhoek . 2012;102(1):121–131. doi: 10.1007/s10482-012-9719-x. [DOI] [PubMed] [Google Scholar]
  • 308.Zhao G, Jiang ZH, Zheng XW, Zang SY, Guo LH. Dopamine transporter inhibitory and antiparkinsonian effect of common flowering quince extract. Pharmacol Biochem Behav . 2008;90(3):363–371. doi: 10.1016/j.pbb.2008.03.014. [DOI] [PubMed] [Google Scholar]
  • 309.Ladero V, Linares D, Pérez M, Del Rio B, Fernández M, Alvarez M. Biogenic amines in dairy products. Microbial toxins in dairy products . 2017:94–131. [Google Scholar]
  • 310.Ozdestan O, Üren A. Biogenic amine content of kefir: A fermented dairy product. Eur Food Res Technol . 2010;231:101–107. [Google Scholar]
  • 311.Yılmaz C, Gökmen V. Formation of tyramine in yoghurt during fermentation – Interaction between yoghurt starter bacteria and Lactobacillus plantarum. Food Research International . 2017;97:288–295. doi: 10.1016/j.foodres.2017.04.014. [DOI] [PubMed] [Google Scholar]
  • 312.Li J, Ren F, Gu H, Li X, Gan B. Safety evaluation in vitro of Enterococcus durans from Tibetan traditional fermented yak milk. J Microbiol . 2011;49(5):721–728. doi: 10.1007/s12275-011-1062-9. [DOI] [PubMed] [Google Scholar]
  • 313.Jabłońska-Ryś E, Sławińska A, Stachniuk A, Stadnik J. Determination of biogenic amines in processed and unprocessed mushrooms from the Polish market. J Food Compost Anal . 2020;92:103492. [Google Scholar]
  • 314.Restuccia D, Spizzirri UG, Luca MD, Parisi OI, Picci N. Biogenic Amines as Quality Marker in Organic and Fair-Trade Cocoa-Based Products. Sustainability . 2016;8(9):856. [Google Scholar]
  • 315.Pastore P, Favaroa G, Badoccoa D, Tapparoa A, Cavallib S, Saccanic G. Determination of biogenic amines in chocolate by ion chromatographic separation and pulsed integrated amperometric detection with implemented wave-form at Au disposable electrode. J Chromatogr A . 2005;1098:111–115. doi: 10.1016/j.chroma.2005.08.065. [DOI] [PubMed] [Google Scholar]
  • 316.Mayr CM, Schieberle P. Development of stable isotope dilution assays for the simultaneous quantitation of biogenic amines and polyamines in foods by LC-MS/MS. J Agric Food Chem . 2012;60(12):3026–3032. doi: 10.1021/jf204900v. [DOI] [PubMed] [Google Scholar]
  • 317.Spizzirri UG, Parisi OI, Picci N, Restuccia D. Application of LC with Evaporative Light Scattering Detector for Biogenic Amines Determination in Fair Trade Cocoa-Based Products. Food Analytical Methods . 2016;9(8):2200–2209. [Google Scholar]
  • 318.Baker GB, Wong JTF, Coutts RT, Pasutto FM. Simultaneous extraction and quantitation of several bioactive amines in cheese and chocolate. J Chromatogr . 1987;392:317–331. doi: 10.1016/s0021-9673(01)94276-1. [DOI] [PubMed] [Google Scholar]
  • 319.Strolin Benedetti M, Tipton KF, Whomsley R. Amine oxidases and monooxygenases in the in vivo metabolism of xenobiotic amines in humans: has the involvement of amine oxidases been neglected. Fundam Clin Pharmacol . 2007;21(5):467–480. doi: 10.1111/j.1472-8206.2007.00498.x. [DOI] [PubMed] [Google Scholar]
  • 320.van der Hoeven N, Visser I. Severe Hypertension Related to Caffeinated Coffee and Tranylcypromine: A Case Report. Ann Intern Med . 2014;160(9):657–658. doi: 10.7326/L14-5009-8. [DOI] [PubMed] [Google Scholar]
  • 321.Balon R, Pohl R, Yeragani VK, Berchou R, Gershon S. Monosodium glutamate and tranylcypromine administration in healthy subjects. J Clin Psychiatry . 1990;51(7):303–306. [PubMed] [Google Scholar]
  • 322.Tucker J, Fischer T, Upjohn L, Mazzera D, Kumar M. Unapproved pharmaceutical ingredients included in dietary supplements associated with US Food and Drug Administration warnings. JAMA Network Open . 2018;1(6):e183337. doi: 10.1001/jamanetworkopen.2018.3337. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 323.Perpetuini G, Tittarelli F, Battistelli N, Arfelli G, Suzzi G, Tofalo R. Biogenic amines in global beverages. Biogenic Amines in Food: Analysis, Occurrence and Toxicity . 2019:133–156. In: Saad B, Tofalo R, eds. [Google Scholar]
  • 324.Ottervanger JP, Klaver MM, Kolling P, Stricker BH. [Intracranial hemorrhage following use of MAO inhibitor tranylcypromine and beer] Ned Tijdschr Geneeskd . 1993;137(18):921–922. [PubMed] [Google Scholar]
  • 325.Jayarajah CN, Skelley AM, Fortner AD, Mathies RA. Analysis of neuroactive amines in fermented beverages using a portable microchip capillary electrophoresis system. Annals of Chemistry . 2007;79(21):8162–8169. doi: 10.1021/ac071306s. [DOI] [PubMed] [Google Scholar]
  • 326.Ancin-Azpilicueta C, González-Marco A, AJiménez-Moreno N. Current Knowledge about the Presence of Amines in Wine. Crit Rev Food Sci Nutr . 2008;48:257–275. doi: 10.1080/10408390701289441. [DOI] [PubMed] [Google Scholar]
  • 327.Costantini A, Vaudano E, Pulcini L, Carafa T, Garcia-Moruno E. An Overview on Biogenic Amines in Wine. Beverages . 2019;5(1):19. [Google Scholar]
  • 328.Visciano P, Schirone M. Update on Biogenic Amines in Fermented and Non-Fermented Beverages. Foods . 2022;11(3):353. doi: 10.3390/foods11030353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 329.Lonvaud-Funel A. Biogenic amines in wines: role of lactic acid bacteria. FEMS Microbiol Lett . 2001;199(1):9–13. doi: 10.1111/j.1574-6968.2001.tb10643.x. [DOI] [PubMed] [Google Scholar]
  • 330.Moreno-Arribas MV, Polo MC. Occurrence of lactic acid bacteria and biogenic amines in biologically aged wines. Food Microbiol . 2008;25(7):875–881. doi: 10.1016/j.fm.2008.05.004. [DOI] [PubMed] [Google Scholar]
  • 331.Mafra I, Herbert P, Santos L, Barros P, Alves A. Evaluation of Biogenic Amines in Some Portuguese Quality Wines by HPLC Fluorescence Detection of OPA Derivatives. American journal of Enology and Viticulture . 1999;50:128–132. [Google Scholar]
  • 332.Gomez-Alonso S, Hermosin-Gutierrez I, Garcia-Romero E. Simultaneous HPLC analysis of biogenic amines, amino acids, and ammonium ion as aminoenone derivatives in wine and beer samples. J Agric Food Chem . 2007;55(3):608–613. doi: 10.1021/jf062820m. [DOI] [PubMed] [Google Scholar]
  • 333.Ginterova P, Marak J, Stanova A, Maier V, Sevcik J, Kaniansky D. Determination of selected biogenic amines in red wines by automated on-line combination of capillary isotachophoresis-capillary zone electrophoresis. J Chromatogr B Analyt Technol Biomed Life Sci . 2012;904:135–139. doi: 10.1016/j.jchromb.2012.07.018. [DOI] [PubMed] [Google Scholar]
  • 334.Marcobal A, Polo MC, Martin-Alvarez PJ, Moreno-Arribas MV. Biogenic amine content of red Spanish wines: comparison of a direct ELISA and an HPLC mehtod for the determination of histamine in wines. Food Research International . 2005;38:387–394. [Google Scholar]
  • 335.Henriquez-Aedo K, Vega M, Prieto-Rodriguez S, Aranda M. Evaluation of biogenic amines content in Chilean reserve varietal wines. Food Chem Toxicol . 2012;50(8):2742–2750. doi: 10.1016/j.fct.2012.05.034. [DOI] [PubMed] [Google Scholar]
  • 336.Hannah P, Glover V, Sandler M. Tyramine in wine and beer. Lancet . 1988;1(1):879. doi: 10.1016/s0140-6736(88)91621-2. [DOI] [PubMed] [Google Scholar]
  • 337.Konakovsky V, Focke M, Hoffmann-Sommergruber K et al. Levels of histamine and other biogenic amines in high-quality red wines. Food Addit Contam Part A Chem Anal Control Expo Risk Assess . 2011;28(4):408–416. doi: 10.1080/19440049.2010.551421. [DOI] [PubMed] [Google Scholar]
  • 338.Leitao M, Marques CAP, Romao MVS. A survey of biogenic amines in commercial Portuguese wines. Food Control . 2005;16:199–204. [Google Scholar]
  • 339.Landete JM, Ferrer S, Polo L, Pardo I. Biogenic amines in wines from three Spanish regions. J Agric Food Chem . 2005;53(4):1119–1124. doi: 10.1021/jf049340k. [DOI] [PubMed] [Google Scholar]
  • 340.Herbert P, Cabrita MJ, Ratola N, Laureano O, Alves A. Free amino acids and biogenic amines in wines and musts from the Alentejo region: evolution of amines during alcoholic fermentation and relationship with variety, sub-region and vintage. Journal of Food Engineering . 2005;66:315–322. [Google Scholar]
  • 341.Hlabangana L, Hernandez-Cassou S, Saurina J. Determination of biogenic amines in wines by ion-pair liquid chromatography and post-column derivatization with 1,2-naphthoquinone-4-sulphonate. J Chromatogr A . 2006;1130(1):130–136. doi: 10.1016/j.chroma.2006.05.090. [DOI] [PubMed] [Google Scholar]
  • 342.Arrieta MP, Prats-Moya MS. Free amino acids and biogenic amines in Alicante Monastrell wines. Food Chem . 2012;135(3):1511–1519. doi: 10.1016/j.foodchem.2012.06.008. [DOI] [PubMed] [Google Scholar]
  • 343.Preti R, Vieri S, Vinci G. Biogenic amine profiles and antioxidant properties of Italian red wines from different price categories. J Food Compost Anal . 2016;46:7–14. [Google Scholar]
  • 344.Nalazek-Rudnicka K, Wojnowski W, Wasik A. Occurrence and Levels of Biogenic Amines in Beers Produced by Different Methods. Foods . 2021;10(12):2902. doi: 10.3390/foods10122902. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 345.Loret S, Deloyer P, Dandrifosse G. Levels of biogenic amines as a measure of the quality of the beer fermentation process: Data from Belgian samples. Food Chem . 2005;89:519–525. [Google Scholar]
  • 346.Koller H, Perkins LB. Brewing and the Chemical Composition of Amine-Containing Compounds in Beer: A Review. Foods . 2022;11(3):257. doi: 10.3390/foods11030257. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 347.Rodríguez-Saavedra M, González de Llano D, Moreno-Arribas MV. Beer spoilage lactic acid bacteria from craft brewery microbiota: Microbiological quality and food safety. Food Research International . 2020;138:109762. doi: 10.1016/j.foodres.2020.109762. [DOI] [PubMed] [Google Scholar]
  • 348.Kalac P, Šavel J, KùíŸek M, Pelikánová T, Prokopová M. Biogenic amine formation in bottled beer. Food Chem . 2002;79:431–434. [Google Scholar]
  • 349.Kalac P, Krízek M. A Review of Biogenic Amines and Polyamines in Beer. Journal of the Institute of Brewing . 2003;109:123–128. [Google Scholar]
  • 350.Kalac P, Hlavatá V, KùíŸek M. Concentrations of five biogenic amines in Czech beers and factors affecting their formation. Food Chem . 1997;58:209–214. [Google Scholar]
  • 351.Anli RE, Vura N, Demiray S, Mert B. Biogenic Amine Content of Beers Consumed in Turkey and Influence of Storage Conditions on Biogenic Amine Formation. Journal of the Institute of Brewing . 2006;112:267–274. [Google Scholar]
  • 352.Buňka F, Budinský P, Čechová M et al. Content of biogenic amines and polyamines in beers from the Czech Republic. Journal of the Institute of Brewing . 2012;118:213–216. [Google Scholar]
  • 353.Pradenas J, Galarce-Bustos O, Henríquez-Aedo K, Mundaca-Uribe R, Aranda M. Occurrence of biogenic amines in beers from Chilean market. Food Control . 2016;70:138–144. [Google Scholar]
  • 354.Tang T, Shi T, Qian K, Li P, Li J, Cao Y. Determination of biogenic amines in beer with pre-column derivatization by high performance liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci . 2009;877(5–6):507–512. doi: 10.1016/j.jchromb.2008.12.064. [DOI] [PubMed] [Google Scholar]
  • 355.Cortacero-Ramırez S, Arraez-Roman D, Antonio Segura-Carretero A, Fernandez-Gutierrez A. Determination of biogenic amines in beers and brewing-process samples by capillary electrophoresis coupled to laser-induced fluorescence detection. Food Chem . 2007;100:383–389. [Google Scholar]
  • 356.Izquierdo-Pulido M, Vidal-Caour MC, Marine-Font A. Determination of biogenic amines in beers and their raw materials by ion-pair liquid chromatography with postcolumn derivatization. J AOAC Int . 1993;76:1027–1032. [Google Scholar]
  • 357.Izquierdo-Pulido M, Vidal-Caour MC, Marine-Font A. Histamine and tyramine in beers: contents and relationship with other analytical data. J Food Compos Anal . 1989;2:219–227. [Google Scholar]
  • 358.Izquierdo-Pulido M, Hernandez-Jover T, Marine-Font A, Vidal-Caour MC. Biogenic Amines in European Beers. J Agric Food Chem . 1996;44:3159–3163. [Google Scholar]
  • 359.Quain DE. Brewing Microbiology . Woodhead Publishing; 2015. 16 - Assuring the microbiological quality of draught beer; pp. 335–354. In: Hill AE, ed. [Google Scholar]
  • 360.Tailor SA, Shulman KI, Walker SE, Moss J, Gardner D. Hypertensive episode associated with phenelzine and tap beer--a reanalysis of the role of pressor amines in beer. J Clin Psychopharmacol . 1994;14(1):5–14. [PubMed] [Google Scholar]
  • 361.Keersmaecker JD. The Mystery of Lambic Beer. Sci Am . 1996;275:74–80. [Google Scholar]
  • 362.Rabie MA, Elsaidy S, el-Badawy AA, Siliha H, Malcata FX. Biogenic amine contents in selected Egyptian fermented foods as determined by ion-exchange chromatography. J Food Prot . 2011;74(4):681–685. doi: 10.4315/0362-028X.JFP-10-257. [DOI] [PubMed] [Google Scholar]

Articles from Psychopharmacology Bulletin are provided here courtesy of MedWorks Media Inc.

RESOURCES